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CHAPTER I 
 
INTRODUCTION 
 
Overview 
All cells are exposed to an array of environmental signals that initiate intracellular 
processes and ultimately orchestrate their behavior. The translation of external signals 
results in a specific molecular response in the cell, including post-translational 
modification of proteins in the form of phosphorylation, ubiquitination and sumoylation 
that stimulate complex macromolecular assemblies acting anywhere from the cell 
membrane to the nucleus. These signal transduction pathways lead to processes as 
diverse as cell proliferation, differentiation, motility and death. The precise execution of 
each process is highly dependent on the rate and specificity of the signaling.  
TBL1 (now known as TBL1X
*
) and TBLR1 are highly homologous proteins that 
function in mediating the Wnt signaling/β-catenin cascade and modulating the 
transcriptional activity of nuclear hormone receptors (NHRs).  TBL1 was first implicated 
in the poly-ubiquitination and proteasomal degradation of β-catenin under conditions of 
cell stress. Subsequently, TBL1 and TBLR1 have emerged as essential transcriptional 
regulators of NHRs, facilitating the exchange between their co-activator and co-repressor 
complexes also through their ability to modulate protein ubiquitination. The mechanistic 
basis for TBL1 family members as functioning regulators of β-catenin and NHRs is 
unknown and is the main focus of my Ph.D. dissertation research.  
                                               
*
 In order to align with previous publication, TBL1 and TBL1X will be used interchangeably in this thesis. 
Other TBL1 homologues will be identified strictly by their formal names (TBLR1, TBL1Y). 
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The TBL1 family of proteins 
The TBL1 gene was first identified in 1999 from patients with Ocular albinism 
with late-onset sensorineural deafness (OASD), who have partial or full deletion of the 
gene linked to the X-chromosome [3]. Subsequently, other TBL1 homologues have been 
identified and included in the TBL1 family comprised of: Transducin β-like 1, located at 
the X chromosome (TBL1X), TBL1X-related 1 (TBLR1) linked to chromosome 3 and 
TBL1Y, the Y-linked homologue of TBL1X [4]. Additional isoforms of X-linked TBL1 
and TBLR1 have also been identified, underlying the diversity of this novel family of 
proteins. Sequence alignment of the proteins demonstrates very high (>80%) sequence 
identity between the different TBL1 homologues [5]. All TBL1 family members consist 
of an almost identical N-terminal LisH dimerization domain followed by a putative FBox 
domain and a C-terminal WD40 repeat domain, the main sequence variability comes 
from the length and sequence of the linker between the FBox and WD40 domains (Fig. 
1.1) [5]. 
 
Figure 1.1. Schematic representation of human TBL1 homologues. TBL1X_i1- 
(isoform 1) and TBL1X_i2 – (isoforms 2).  
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TBL1 and TBLR1 are essential factors mediating the function of transcriptional 
co-activator β-catenin and nuclear hormone receptors [6-7]. TBL1Y is the least studied 
family member and its role has not been determined yet. Despite the high sequence 
identity between TBL1 and TBL1Y, the function of TBL1 cannot be compensated by 
TBL1Y. TBL1 is ubiquitously expressed in almost all tissues and bypasses X-
chromosome inactivation [4]. TBL1Y has been proposed to have an essential distinct role 
in maleness.  
TBL1 and TBLR1 share a diverse set of binding partners, yet most partners have 
preferentially higher affinity for one of the TBL1 homologues. Direct interaction of 
TBL1 family members have been demonstrated with β-catenin, TCF4, NCoR, SMRT, 
GPS2, CtBP1/2, Histone 2B (H2B), H4 and the 19S proteasome [6, 8-11]. Most of these 
interactions occur in the context of large multi-protein assemblies. Very little is known 
about the mechanism of assembly, specificity and release of these complexes. Recent 
studies have demonstrated that the function of TBL1 and TBLR1 is mediated by unique 
phosphorylation sites: Ser173, Thr334 and Ser420 for TBL1 and Ser123 and Ser199 for 
TBLR1 [10]. However, the basis of how TBL1 and TBLR1 facilitate this diverse set of 
interactions, as well as their regulation and functional outcome, is not known. 
The first evidence for the role of TBL1 in mediating the formation of complexes 
that target proteins for ubiquitination and degradation comes from investigating the 
function of Ebi, the Drosophila homologue of TBL1. In Drosophila, the transcriptional 
repressor Tramtrack 88 (Ttk88) is recruited and poly-ubiquitinated by the Sina (Siah-1 
homologue)/Phyllopod (Phyl)/Ebi complex for proteasomal degradation [12]. In a similar 
manner, mammalian TBL1 recruits non-phosphorylated β-catenin to Siah-1, which 
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mediates its poly-ubiquitination and degradation upon UV-induced DNA damage [13]. 
Despite the functional data from humans and Drosophila demonstrating the interplay 
between Siah-1 and TBL1 in substrate recruitment and ubiquitination, little is known 
about the specific mechanism of action in these functions.  
 
Protein Ubiquitination 
Post-translational modification of proteins by the covalent attachment of ubiquitin 
was initially discovered by Aaron Ciechanover, Avram Hershko and Irwin Rose in the 
early 1980s as a signal that targets substrates for degradation [14-16]. Since then, this 
finding was quickly expanded by an immense body of evidence demonstrating that post-
translational modification by the attachment of ubiquitin serves many other purposes 
including chromatin remodeling, protein localization, cell cycle control, gene regulation 
and DNA repair [17]. Thus, this ubiquitous post-translational modification affects every 
aspect in the life, regulation and sustainability of the cell. Extensive in-depth reviews of 
various aspects of ubiquitination have been published [18-21]; a brief summary of the 
ubiquitination mechanism is presented below. 
 
Mechanism of protein ubiquitination 
Protein turn-over, the process of hydrolyzing the peptide backbone back to the 
basic amino acids for reuse, is essential to the maintenance of a stable and balanced 
cellular environment. The precise level of proteins in the cell is tightly regulated through 
coordination of the rate of protein synthesis and turnover. Post-translational modification 
of substrates by the covalent attachment of multiple ubiquitin moieties serves as a 
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tag/signal that is recognized by the 26S proteasome for degradation. The covalent 
attachment of ubiquitin to targets involves a cascade of enzymatic reactions carried out 
by the ubiquitin activating enzyme, E1, ubiquitin conjugating enzyme (E2), and ubiquitin 
ligating enzyme (E3) [16]. Ubiquitin is a small, 76 residue protein. It is activated by the 
E1 in an ATP-dependent manner to form a thioester bond between the E1 catalytic Cys 
and the C-terminal Gly residue of ubiquitin (Fig. 1.2). The ubiquitin~E1 complex recruits 
the E2 and transfers the covalently attached ubiquitin from the E1 to the catalytic Cys of 
E2. The final step of the ubiquitin transfer is catalyzed by the E3 ligase, which serves to 
recruit and catalyze the E2~ubiquitin (Ub) complex and the substrate as well as to 
activate the E2~Ub conjugate, resulting in transfer of a ubiquitin to lysine on the 
substrate. The process can be repeated multiple times, resulting in ubiquitination of other 
lysines on the substrate, as well as on the ubiquitin moieties of the ubiquitinated substrate 
[19].  
 
Figure 1.2. Schematic overview of the ubiquitin conjugation cascade. 1) The ubiquitin 
activating enzyme, E1 reacts with ubiquitin to form an activated ubiquitin~E1 complex by 
forming a thioester bond, in an ATP-driven reaction. 2) This step is repeated for the non-
covalent attachment of a second ubiquitin to E1. 3) The E1 loaded with two ubiquitins 
binds the E2, ubiquitin conjugating enzyme. 4) The first covalently attached ubiquitin 
from the E1 is transferred to the E2 forming a thioester bond. 5) The E3 ligating enzyme, 
recruits an E2~Ubiquitin complex and a substrate to facilitate the transfer of ubiquitin to 
the substrate. Multiple cycles of E2~Ub complex recruitment are necessary for the 
formation of a poly-ubiquitin chain. 
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E3 ubiquitin ligases: recruiting substrates for ubiquitination 
Substrate specificity is determined largely by the E3 ubiquitin ligases, based on 
the nature of their substrate-recruiting domains. The E3 enzymes can be broadly 
classified into two general subgroups: (i) simple E3 ligases, for which a single molecule 
performs the recruitment, activation and transfer of ubiquitin from E2 enzyme to the 
substrate; (ii) complex E3 ligases, represented by multi-protein assemblies that mediate 
the recruitment of the substrate, activation of the E2~Ub complex and transfer of 
ubiquitin. E3s are classified on the basis of their E2-binding domain as HECT 
(homologous to E6AP C-terminus), RING (really interesting new gene), and U-box 
(Ufd2-box) E3 ligases. The Cullin-RING ligases (CRLs) are the most well studied E3 
ligases; they utilize a RING-module for the recruitment of E2~Ub [18].  
HECT family of E3 ligases: HECT E3 ligases have at least 2 distinct domains, an 
E2- and a protein-protein binding domain. The transfer of ubiquitin to a substrate by 
HECT enzymes is a two step process that involves simultaneous recruitment of the 
substrate and the E2~Ub complex (Fig. 1.3A). First, ubiquitin from the E2 is transferred 
to a catalytic Cys on the HECT domain itself by forming an E3~Ub thioester, followed 
by transfer of ubiquitin from the E3~Ub intermediate complex to a Lys residue on the 
substrate.   
RING and U-box family of simple E3 ligases: The RING and U-box domains of 
E3 ligases are structurally similar and both recognize diverse E2 enzymes. The general 
architecture and mechanism of RING/U-box ligases is similar to HECT proteins. They 
have a distinct substrate-binding domain and a RING/U-box domain that recruits specific 
E2 enzymes. The main difference is that the ubiquitin molecule is transferred directly 
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from the RING- or U-box-bound E2 to the targeted Lys on the substrate (Fig.1.3B). It 
was initially proposed that U-box ligases function as E4 ligases by extending the 
ubiquitin chains on an ubiquitin primed substrate [22]. However, U-box enzymes, such as 
CHIP and E4B can form poly-ubiquitin chains independent of other E3 ligases [23-24]. 
Complex E3 ligases, CRLs: The complex Cullin-RING ligases (CRLs) are the 
most abundant and well studied of the E3 ubiquitin ligases [18]. These include SCF (Skp-
Cullin-FBox) E3 ligases, which are assembled using one of the Cullin family members as 
a molecular scaffold for bringing together the other components (Fig. 1.3C). In the 
paradigm SCF complex, SCF
βTrCP
, the C-terminal domain of Cullin serves to recruit the 
RING-E3 protein Rbx1. The adaptor protein Skp1 is bound to the N-terminal region of 
Cullin and to the FBox domain of the substrate-recruiting protein. Once the complex is 
formed, SCF E3 ligases follow a direct mechanism of ubiquitin transfer from the E2~Ub 
complex to the substrate, similar to simple RING E3 ligases (Fig. 1.3A, C). 
The substrate of the SCF E3 ligase is specified by one of the large family of 
substrate receptors. Substrates are bound to either a WD40 repeat, leucine-rich repeat 
(LRR), Kelch, carbohydrate binding and sugar hydrolysis (CASH) or Zinc finger domain 
[21]. The most abundant of these substrate binding domains are WD40 and LRR 
domains.  
A specific binding motif for substrate interaction with SCF ligases has been 
identified, which is termed a phosphodegron, because it requires specific serines and 
threonines of the substrate to be phosphorylated. The number of phosphorylated residues 
in the phosphodegron has been associated with the rate of substrate poly-ubiquitination 
and degradation [25]. Other post-translational modifications including the addition of 
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oligosaccharides or a hydroxyproline epitope are also recognized by substrate receptors 
of E3 ligases, thereby expanding the diversity and specificity of protein ubiquitination 
[18, 21, 25-26].    
 
 
 
 
Figure 1.3. Representation of the E3 ubiquitin ligase subfamilies. A) RING/U-box 
ubiquitin ligases. Direct transfer of ubiquitin from the E2~Ub complex to the substrate; 
B) HECT ubiquitin ligases. Indirect transfer of ubiquitin from the E2~Ub first to the E3 
(step 1), then to the substrate (step 2); C) Cullin-RING ubiquitin ligases. Formation of 
multi-protein complex that facilitates the direct transfer of ubiquitin from the E2~Ub to 
the substrate.  
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Physiological role of ubiquitin linkages 
The functional readout of substrate ubiquitination depends on the number of 
ubiquitins added and the type of linkages formed. Mono-ubiquitination is the attachment 
of a single ubiquitin molecule to a Lys residue on the substrate, whereas ligation of a 
single ubiquitin to more than one of the Lys residues of the substrate is termed multi-
monoubiquitination (Fig. 1.4A). Ubiquitin itself has seven Lys residues that are able to 
accept another ubiquitin moiety, which can lead to formation of either homogeneous 
linear: Lys6, Lys11, Lys27, Lys29, Lys33, Lys48 and Lys63, or heterogeneous or 
branched poly-ubiquitin chains (Fig. 1.4B). The functional effect of poly-ubiquitination is 
dictated by the type of chain. This can be understood in part by differences in structure of 
the poly-ubiquitin chain. For example, tightly packed Lys48 chains are structurally 
different from extended Lys63-linked poly-ubiquitin chains [27-28].  
Recent advances in mass-spectrometry have been very instrumental in 
determining the identity of ubiquitin chains on specific substrates, although mapping the 
functional outcome associated with a specific chain type remains a challenge. In general, 
proteins with Lys48 and Lys11 linked ubiquitin chains are recognized by the 26S 
proteasome for degradation, whereas Lys63 chains are identified on substrates involved 
in DNA damage or cellular trafficking (Fig. 1.4C) [29-30]. The functional relevance of 
linkages through Lys27, Lys29 and Lys33 is not well understood, in part due to technical 
difficulties in identifying them in mass spectrometry experiments.  
As noted above, besides homogeneous “linear” ubiquitin linkages, where only a 
single ubiquitin is added to a specific ubiquitin moiety on a substrate, branched or forked 
poly-ubiquitin chains can be formed. In these chains at least one ubiquitin moiety is 
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covalently bound to two or more ubiquitins (Fig 1.4C) [31]. The exact functional 
relevance of the branched and forked chains is not firmly established. However, evidence 
has accumulated suggesting that forked poly-ubiquitin chains prevent degradation of the 
substrate by the 26S proteasome [30-31]. 
 
Figure 1.4. The ubiquitin signal. A) Ubiquitination forms from the attachment of a 
single ubiquitin to one (mono-ubiquitination) and many (multi-monoubiquitination) 
target site(s) on the substrate. B) The structure of ubiquitin where the seven lysine 
residues that function as acceptors for another ubiquitin molecule are colored in red. C) 
Types and functional relevance of poly-ubiquitin linkages.  
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Protein deubiquitination 
Post-translational modification by ubiquitin is a reversible process. The covalent 
bond between ubiquitin and substrate can be hydrolyzed by a diverse family of proteases 
in a process called deubiquitination. Deubiquitinating enzymes (DUBs) are essential in 
determining the fate of ubiquitinated substrates by either removing the ubiquitin chain 
from the substrate or by editing the assembled linkage on the substrate [32-33]. Since the 
proteasome recognizes ubiquitin chains with a minimum of four ubiquitin molecules, 
editing already assembled linkages provides a DUB-dependent rate of substrate 
recruitment and degradation by the proteasome. Thus, DUBs introduce an additional 
means of regulation to control the levels of proteins in cells. DUBs have another role 
once substrates are degraded: their activity enables recycling of poly-ubiquitin chains 
released from the proteasome and free ubiquitin chains that are synthesized in the cell 
[33]. 
Notably, the proper function of deubiquitinating enzymes is also crucial for the 
ubiquitination process itself. Ubiquitin is actively expressed as a pro-ubiquitin molecule, 
a free linear poly-ubiquitin as a fusion to a ribosomal protein. DUBs provide the 
proteolytic activity required to generate single ubiquitin moieties Activation by DUBs 
includes cleavage of C-terminal residues of pro-ubiquitin, which must be trimmed to 
leave the Gly-Gly end required for function in ubiquitin ligation reactions.  
 
Ubiquitination and disease 
Since the ubiquitination machinery plays an essential role in keeping the levels 
and activity of many cellular proteins in check, defects in the ubiquitin cascade or 
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mutations in the substrate that reduce or abrogate binding to the E3 can lead to 
aberrations in the ubiquitination process resulting in a variety of diseases from cancer to 
neurodegenerative disorders. For example, mutations in the BRCA1 and BRCA2 E3 
ligases leads to increased susceptibility to breast and ovarian cancer, and mutations in the 
Parkin E3 ligases are associated with Parkinson’s disease [18, 34]. 
Interestingly, the ubiquitin-proteasome machinery has also been identified as a 
direct target of many oncogenic viruses such as human papillomavirus (HPV), Epstein 
Barr virus (EBV) and the adenovirus [35-36]. A common mechanism of these tumor 
viruses is to either modulate host E3 ligases or to produce viral ubiquitination and 
deubiquitination machinery in the host cell. Major signaling pathways such as the Wnt/β-
catenin pathway are directly targeted by tumor viruses as are oncogenes including p53, c-
Myc and cyclin D1 proteins [35]. Therefore, understanding the mechanisms of host and 
viral mediated ubiquitination and deubiquitination processes offers promise as a means to 
develop therapeutics, targeting key cancer proteins. 
 
The role of TBL1 in mediating the function of β-catenin 
β-Catenin is a ubiquitous transcriptional activator in the canonical Wnt signaling 
pathway. Wnt signaling is integral to many cellular processes including cell proliferation, 
cell fate and survival and adult stem cell differentiation and oncogenesis [37-38]. 
Regulation of β-catenin by the Wnt pathway is highly conserved throughout all animal 
species. The ability to study β-catenin in an array of model organisms has enabled 
numerous crucial discoveries. Importantly, this basic developmental pathway is directly 
associated with cancer. 
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Tight control of β-catenin levels and function is critical for the timely expression 
of Wnt target genes during embryogenesis and in adult homeostasis. Not surprisingly, 
mutations in β-catenin and regulatory factors from the Wnt pathway are associated with 
many cancers in addition to cardiovascular diseases, osteoarthritis and neurodegenerative 
diseases such as Alzheimer’s and schizophrenia [37-39].  
Defects and inappropriate stabilization of β-catenin are often associated with the 
initiation and progression of cancers such as breast, colorectal and ovarian [40-41]. One 
of the first discoveries that linked β-catenin to cancer was the identification of direct 
interaction with Adenomatous Polyposis Coli (APC) [42-43]. Loss of function mutations 
in APC that prevent its interaction with β-catenin or the SCFβ-TrCP E3 ligase are found in 
many patients with colorectal cancers [39]. Furthermore, mutations of Ser33, Ser37, 
Thr41 and Ser45, which are part of the β-catenin phosphodegron, have been identified in 
patients with melanoma, colorectal, hepatocellular and gastric cancers [37].  
Considering that defects in the Wnt/β-catenin pathway are strongly implicated in 
the pathogenesis of proliferative diseases, many components of this pathway have 
become targets for anti-cancer drug discovery [38, 44]. The challenge of interrupting or 
stimulating specific β-catenin-protein complexes without effecting other interactions is 
being actively pursued. Understanding the mechanisms that lead to the stabilization of β-
catenin in its oncogenically active state and activation of Wnt target genes is currently 
being investigated and constitutes one of the primary motivations for my research. 
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Regulation of β-catenin by the Wnt signaling pathway 
The Wnt signaling pathway controls cellular levels and the activity of β-catenin 
(Fig. 1.5). Wnt ligands are small Cys-rich glycoproteins utilized for short-range 
signaling. In the absence of Wnt ligands, β-catenin is phosphorylated by casein kinase I 
(CK1) and glycogen synthase kinase 3 β (GSK3β) [38]. Phosphorylated β-catenin is 
recognized and poly-ubiquitinated by the SCF
β-TrCP
 E3 ligase, which targets it for 
degradation by the 26S proteasome (Fig. 1.5, Left) [37-38, 45]. Low β-catenin levels in 
the cell lead to its nuclear depletion, which results in T cell factor/Lymphoid enhancer 
factors (Tcf)/(Lef) transcription factors remaining in a repressed state, thereby preventing 
the expression of the Wnt target genes. 
When Wnt ligands are secreted, GSK3β and other factors are recruited to the 
Frizzled transmembrane receptor, reducing poly-ubiquitination and degradation of β-
catenin (Fig. 1.5, Right). Increased local concentration of β-catenin in the cytoplasm 
leads to its nuclear translocation. TBL1 and TBLR1 directly bind β-catenin and recruit it 
to the promoter site of Tcf/Lef factors, where β-catenin forms an activation complex with 
Pygopus and Bcl-9 [6, 37]. The formation of an activation complex displaces 
transcriptional repressors TLE1, HDACi and Groucho from the Tcf/Lef factors and 
triggers the expression of Wnt induced genes. Notably, TBL1 and TBLR1 are always 
found present at the promoter site in both the “on” and “off” states of the Wnt target 
genes [6, 37]. The activation of Wnt enhanced promoters by β-catenin contributes to the 
expression of many genes including: cyclin D1, c-Myc, AXIN2, SOX9 and vascular 
endothelial growth factor (VEGF). The activation of these genes is important in 
processes ranging from cell proliferation (cyclin D1, c-Myc and SOX9) to development 
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(AXIN2) to signaling and cell motility (VEGF), which in turn highlights the importance 
of transcriptional activation by β-catenin in human physiology [37-38].   
Figure 1.5. The Wnt signaling cascade. (Left) In the absence of a Wnt ligand, β-catenin is 
recruited for phosphorylation by GSK3β and CK1. Phosphorylated β-catenin is recognized 
for poly-ubiquitination by the SCF
βTrCP
 complex, leading to its degradation by the 26S 
proteasome. (Right) In the presence of a Wnt ligand, the protein complex that recruits β-
catenin for phosphorylation is localized to the cellular membrane. This prevents β-catenin 
from phosphorylation, leading to its accumulation in the cytoplasm and translocation to 
the nucleus. β -Catenin is recruited to the promoter site of Wnt genes, targeting their 
expression.  
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Degradation of β-catenin by the SCFβ-TrCP E3 ubiquitin ligase 
The critical role in transcriptional activation of genes has prompted investigation 
of post-translational modification and turnover of β-catenin. In 1997, Aberle and 
colleagues showed for the first time that the level of β-catenin is decreased by 
ubiquitination-mediated degradation in the proteasome [46]. Down regulation of β-
catenin occurs only in the absence of Wnt ligands; expression of Wnt ligands suppresses 
the degradation process [46]. Soon after this report, it was shown that APC and AXIN2 
recruit CK1 and GSK3β kinases and stimulate phosphorylation of β-catenin at Ser29, 
Ser33, Ser37, Thr41 and Ser45 [45, 47]. Phosphorylated β-catenin is recognized by the 
WD40 domain of β-TrCP, leading to poly-ubiquitination by the SCFβ-TrCP E3 ubiquitin 
ligase. The assembly of poly-ubiquitin chains on Lys19 and Lys49 targets β-catenin for 
proteasomal degradation [1, 48]. 
 
Figure 1.6. Structural model of SCF
β-TrCP 
- β-catenin complex (reproduced based on the 
model in [1]). The extended modular architecture of Cullin facilitates the recruitment of 
phosphorylated β-catenin substrate through the Skp1-β-TrCP module and the RING-
Rbx1 protein that binds the E2~Ub complex. Computation methods have been used to 
calculate an estimated distance from the active cystein of an E2 to the substrate to be 
~50Å.  
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A structural model of SCF
β-TrCP
 ligase in complex with phosphorylated β-catenin 
peptide has provided critical insights into the mechanism of substrate ubiquitination 
(Fig.1.6) [1]. The x-ray crystal structure of β-TrCP with β-catenin (residues 19-44) in 
combination with mutagenesis and in vitro ubiquitination studies have identified the 
sequence specificity of the doubly-phosphorylated phosphodegron, sufficient for the 
binding and ubiquitination of the β-catenin substrate. Asp32 and Gly34 in addition to the 
phosphate groups of pSer33 and pSer37 are critical for the strong binding with the WD40 
β-propeller of β-TrCP. Based on the structural and biochemical experiments on β-catenin 
targeted ubiquitination by the SCF
β-TrCP
 complex, the rate determining factor for ubiquitin 
chain assembly is proposed to be dependent on the position of a specific Lys residue on 
the β-catenin target sequence with respect to the residues in direct contact with the basic 
WD40 surface [1].  
 
Siah-1-targeted degradation of β-catenin by an SCFTBL1-like complex 
Nearly a decade ago, a novel β-catenin ubiquitination pathway was discovered in 
cells stressed by UV-induced DNA damage [13].  Remarkably, this pathway targets the 
non-phosphorylated form of β-catenin. UV-induced DNA damage activates p53, which 
induces the overexpression of a RING E3 ligase, Siah-1. Increased levels of Siah-1 lead 
to the formation of an SCF-like complex comprised of Siah-1, Siah-1 Interacting Protein 
(SIP), Skp1, TBL1 and APC [13, 49]. Siah-1 binds the E2 ubiquitin conjugating enzyme 
through its RING domain and is linked to substrates through SIP, Skp1 and TBL1. TBL1 
plays the key role in this complex by directly contacting non-phosphorylated β-catenin 
(Fig. 1.7). APC is associated with both β-catenin and Siah-1, and appears to play a 
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regulatory role in β-catenin localization, but its exact function has not yet been 
determined [50]. Even though Siah-1 does not form a prototypical SCF E3 ligase that 
contains a Cullin protein, it was named based on the established convention for SCF 
multi-protein E3 ligases: SCF
TBL1
.   
The substitution of SIP for the Cullin scaffolding protein has important 
implications for the SCF
TBL1
 complex because SIP and Cullin have very different 
architectures. Cullins are almost four times larger than SIP (~800 vs 229 residues). Since 
both Cullin and SIP serve as scaffolds in their respective complexes, the differences in 
their structures imply that existing SCF models would not be accurate representation of 
the SCF
TBL1 
complex. Moreover, both TBL1 and Siah-1 exist as oligomeric proteins [51-
52]. Thus, despite the wealth of structural and biochemical information about SCF E3 
ligases, at the start of this thesis work almost nothing was known about the mechanism of 
SCF
TBL1
-mediated recruitment and poly-ubiquitination of non-phosphorylated β-catenin.   
 
 
Figure 1.7. Schematic representation of the proposed SCF
TBL1
-like E3 ubiquitin ligase. 
Overexpression of Siah-1-mediates the recruitment of SIP, which interacts with the 
adaptor protein Skp1. TBL1 binds the non-phosphorylated β-catenin substrate and recruits 
it to the SCF-like complex for poly-ubiquitination through cycles of E2~Ub complexes 
that bind RING-Siah-1 E3 ligase. TBL1 and Siah-1 are shown as monomers in this 
diagram for clarity of representing the complex.  
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The role of TBL1 in regulating the activity of nuclear hormone receptors 
A wealth of knowledge about NHRs has accumulated over more than 100 years 
and has its roots from 1903, when Bayliss and Starling used the Greek work “hormone”, 
which means “I stimulate”, to characterize the chemical secretions from the pancreas. 
These early studies initiated the science of endocrinology and the idea of chemical 
messengers. Since then, science has unraveled the immense impact that mistakes in the 
regulatory pathways of NHRs have on a wide range of pathophysiologies from cancer to 
metabolic diseases such as diabetes [53].  
NHRs are a large structurally related family of modular proteins that regulate 
many processes during development, differentiation and homeostasis [54-55]. They 
represent a superfamily of transcription factors activated by steroids and thyroid 
hormones as well as vitamins and numerous other small ligands. These modular proteins 
contain a conserved DNA binding domain (DBD) and a C-terminal ligand binding 
domain, both of which contribute to the formation of homo- and hetero-dimers. The N-
terminal region is unstructured, has the highest degree of sequence variability within the 
NHR family members, and is responsible for the specificity of diverse protein 
interactions [54-55].  
NHRs are divided into two major subfamilies: steroid receptors, such as the 
glucocorticoid receptors and estrogen receptors (ER); non-steroid receptors that include 
thyroid receptors, Vitamin D receptors and retinoic acid receptors [53, 56]. The activation 
pathways of the two receptor subfamilies differs mostly by the essential role that Heat 
shock proteins, Hsp70 and Hsp90, play in activating the steroid, but not the non-steroid 
receptors. Unliganded steroid receptors are localized predominantly in the cytoplasm and 
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upon ligand stimulation they form a complex with Hsp70 or Hsp90 chaperones, which 
mediate their nuclear translocation. Localization of steroid receptors to the nucleus leads 
to the dissociation from the heat shock proteins and formation of receptor homodimers at 
the promoter site of target genes. The association of ligand-bound receptors to the 
promoter facilitates the interaction with hormone elements and regulatory co-activator 
complexes that together trigger the expression of specific target genes.  
Non-steroid receptors are activated and recruited to the promoter site of target 
genes independently of heat shock proteins [53, 56]. Ligand binding to the receptor leads 
to dissociation of the homodimers and formation of the more favorable heterodimer, 
which in turn is recruited to the response elements at the promoter site of target genes. In 
a similar manner to steroid receptors, the activation of gene expression requires the sum 
of many interactions from macromolecular assemblies of co-activators and signaling 
proteins, which at the end results in turning the transcriptional switch at the promoter 
“on” or “off”.  
 
TBL1-mediated transcriptional regulation of nuclear hormone receptors 
 Critical advances in understanding the dynamic mechanism of transcriptional 
regulation by NHRs have come from Chromatin Immunoprecipitation (ChIP) 
experiments using Estrogen Receptor α (ERα). Estradiol-bound ER is recruited to the 
promoter followed by activator complexes that initiates the expression of ER-driven 
genes [57-58]. Importantly, this event cycles with recruitment of the proteasome, which 
leads to subsequent degradation of the receptor and activator complexes, and replacement 
by co-repressor complex and the unliganded receptor [59]. The dynamic regulatory 
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exchange of these large protein machineries and the essential role of the proteasome in 
switching between activators and repressors have become the standard model for 
transcriptional regulation by NHRs.  
 In 2004, Perissi and colleagues demonstrated that TBL1 and TBLR1 are essential 
factors for the transcriptional activation of nuclear receptors, and absolutely necessary 
components in both the repressor and activator complexes of NHRs (Fig. 1.8) [60]. 
Notably, despite their high sequence identity, TBL1 and TBLR1 are not functionally 
redundant and show clear preference for activators or repressor of NHRs. Further 
analyses of the function of TBL1 proteins have shown that they recruit the 19S 
proteasome and mediate the ubiquitination and degradation of NHR and their co-factors 
at the promoter site (Fig. 1.8) [7, 60]. The mechanism that dictates the role of TBL1 
scaffolding proteins in the precise exchange of these factors is still unknown and an 
active area of research in the field. 
 
Therapeutic potential 
 Given the enormous impact that NHRs have on diverse physiological processes 
and their function via central signaling pathways and dynamic multi-protein machineries, 
it is not surprising that functional defects would result in disease. Defects in the function 
of NHRs have a physiological impact that ranges from proliferative, reproductive and 
metabolic conditions such as type II diabetes, obesity, cardiovascular diseases, infertility 
and many types of cancer [61-62]. 
 Structural characterization of NHRs has promoted their consideration as drug 
targets and a number of therapeutics directed to the receptor superfamily have already 
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Figure 1.8. Mechanism of exchange between NHR co-activator (Co-A) and co-
repressor (Co-R) complexes. (i) The ligand bound NHR recruits a Co-A complex in 
the presence of TBL1 and TBLR1. The formation of the multi-protein assembly leads 
to the transcriptional activation of HR target genes. (ii) The exchange of Co-A for 
Co-R complex, requires TBL1 mediated poly-ubiquitination and recruitment of the 
proteasome that leads to the degradation of Co-A components. (iii) TBL1 proteins 
replace the Co-A complex with the Co-R complex, which results in transcriptional 
inhibition of NHR target genes. (iv) Ligand induced stimulus targets the recruitment 
of an E3 ligase and the 19S proteasome by TBL1, leading to the proteasomal 
degradation of the Co-R complex and its exchange of a Co-A complex.  
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 been developed [54]. However, although therapeutics that can specifically target NHR 
have been designed, a single receptor can activate multiple genes, which ultimately 
results in a drug with significant side effects. The current focus is on new therapeutics 
that recognize specific post-translational modifications and mediate the function of multi-
protein assemblies [54]. Since TBL1 and TBLR1 are essential scaffolding proteins for 
these complexes, understanding their mechanism of function and how they mediate the 
exchange of co-activator and co-repressor complexes in activating NHRs will provide 
new avenues to pursue for identifying therapeutics.  
 
Experimental Methods for Structural Analysis 
Analytical Ultracentrifugation 
Analytical ultracentrifugation (AUC) is a biophysical method used to analyze the 
molar mass and shape of a molecule and the stoichiometry and association constants of 
molecular complexes [63]. Two types of AUC experiments are typically performed: 
sedimentation velocity (SV) and sedimentation equilibrium (SE) [64-65]. In an SV 
experiment, the sedimentation of a molecule away from the center of rotation is 
monitored at high centrifugal speed, 40,000 – 60,000 rpm. Based on hydrodynamic 
principles, the data provides information about the size and shape of the molecule in 
solution. SE runs are performed at lower centrifugal speed, 15,000 – 30,000 rpm, where 
the sedimentation and back diffusion of the molecule are at equilibrium. Based on 
thermodynamic principles, the data is used to calculate the molar mass, stoichiometry and 
association constant of proteins and protein complexes in solution [63].  
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Analysis of the SV data can provide estimates of biophysical parameters such as the 
frictional ratio and the Stokes radius [64-65]. The frictional ratio, f/fo is the 
experimentally determined frictional coefficient of a hydrated molecule divided by the 
calculated, non-hydrated spherical molecule with the same molar mass and gives 
information directly related to the shape of the molecule. Highly globular proteins have a 
lower frictional ratio, compared to proteins with elongated structural architectures. The 
Stokes radius, Rs, also known as the hydrodynamic radius of a molecule, relates to the 
radius of a hard sphere that diffuses at the same rate as the molecule.  
For this thesis work, AUC velocity experiments were acquired with an ultracentrifuge 
cell with two separate sectors. One sector is used for the protein sample and the other 
used as a reference for the solvent. The loaded cell is placed in a rotor and the 
sedimentation of the sample monitored in real time through an optical system while 
centrifuged at 40,000 rpm. Analysis of the concentration distribution of the sample over 
time is performed with the program sedfit [63-64].  This analysis provides a direct 
measurement of the sedimentation coefficient, s (S), which represents the rate of 
migration of a molecule per unit field, determined using s = ν / (ω2r) = Mb / f, where ν is 
the volume of the particle, ω the rotor speed, r the distance from the center of the rotor, 
Mb the buoyant molar mass and f the frictional coefficient [63-64].  
In this thesis work, data from the velocity AUC experiments of TBL1 have been used 
to determine the oligomerization state of the protein. Furthermore, calculating the 
frictional ratio and the Stokes radius of the protein have been essential parameters in 
generating the structural model of TBL1 using SAXS (chapter III).      
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Nuclear magnetic resonance 
Nuclear Magnetic Resonance (NMR) spectroscopy is a very sensitive and powerful 
technique used primarily for determining molecular structure, characterizing molecular 
dynamics and for mapping inter-molecular interactions. The NMR phenomenon arises 
from the precession of nuclear spins when placed in the presence of a magnetic field. The 
NMR frequency serves as a signature of the electronic structure surrounding the nucleus. 
NMR analysis is largely based on the detection of scalar (through-bond) and dipolar 
(through-space) couplings between nuclei. Over the past 30 years, the development of 
multi-dimensional, multi-nuclear experiments has enabled the study of large, complex 
molecules such as proteins.  
 NMR experiments on proteins are typically performed on samples with enrichment 
in one or more stable NMR-active isotopes such as 
15
N, 
13
C and 
2
H. In a 2D 
15
N-
1
H 
HSQC (Heteronuclear Single Quantum Correlation) spectrum, each of the peaks 
represents the correlation of the 
1
H and 
15
N resonance frequencies of each amide in the 
protein. Since each peak arises from a different amino acid, this spectrum provides a 
powerful fingerprint of the protein structure.  
Transverse relaxation optimized spectroscopy (TROSY)–HSQC experiments are 
often utilized to investigate large proteins or protein complexes, where the slow tumbling 
of the molecules leads to faster relaxation and correspondingly, larger line width [66]. It 
turns out that the resonances of even a simple, two-spin 
15
N-
1
H system, is composed of 
four components, which relax at different rates. TROSY filters out the fastest relaxing 
components leaving only the slow relaxing components. This leads to the ability to 
observe signals for larger molecules and much narrower resonances. Maximum TROSY 
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sensitivity requires acquisition of spectra at magnetic field strengths corresponding to 700 
MHz or greater and deuteration of proteins.  
Based on the peak distribution in an 
15
N-
1
H HSQC spectrum, essential information 
can be obtained in regards to the extent of ordered structure and stability of a protein. The 
chemical shifts of a globular protein are well dispersed in the 
1
H dimension, whereas for 
an unfolded protein the range is significantly collapsed. Once the conditions for 
collecting a good HSQC spectrum of the protein have been established, additional 
experiments can be performed to assign each peak to the specific amino acid of the 
protein, which is the necessary prerequisite for any detailed NMR analysis such as 
mapping the interaction site of a binding partner or pursue structure determination.  
The main application of NMR in this thesis work has been to confirm a direct 
physical interaction between two proteins using chemical shift perturbation assays. In 
these experiments, 
15
N-labeled protein is used to record 
15
N-
1
H HSQC spectra alone and 
after titration of unlabeled binding partner. The unlabeled protein produces no signal, but 
the NMR chemical shifts of residues at the binding interface will be perturbed as the 
ligand is titrated. The chemical shifts are highly sensitive to the electronic environment of 
the nucleus therefore, direct physical contact between the two proteins leads to alterations 
in the chemical shifts at the binding interface. Ligand-induced conformational change of 
the labeled protein would also result in chemical shift perturbations at sites that may be 
remote from the binding site. Hence, careful evaluation of the data is required. The 
reciprocal experiment is often performed, switching which protein is isotopically labeled, 
in order to confirm the direct physical interaction between the two proteins and to map 
the binding site on the binding partner.  
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The protein-protein interactions investigated by NMR assays in this thesis work 
involved large proteins (between 30 and 85 kDa). In such cases, the larger protein 
complex can lead to increased relaxation rates and broadening of the signals below the 
detection limit in an HSQC spectrum. In these instances, definitive evidence for a direct 
protein interaction can be obtained by evaluating spectra under sub-stoichiometric 
conditions, i.e. with less than a molar equivalent of the unlabeled titrant [67-68]. When 
very small amounts of titrant are added, in favorable cases, it is possible to observe 
chemical shift perturbations and/or increases in line width of a select number of NMR 
signals that arise from residues at the binding interface [68].  
In this work we showed the direct physical interaction between Siah-1 (44 kDa) and 
β-catenin (64 kDa) using TROSY-based NMR chemical shift perturbation assay (chapter 
II). 
 
Small angle x-ray scattering 
Small angle x-ray scattering (SAXS) is a powerful technique for obtaining low 
resolution structural information about the size, shape and the conformational dynamics 
of a molecule or molecular complex in solution. In a small angle scattering experiment, 
the sample is exposed to a monochromatic flux of highly-focused x-rays. The scattered x-
rays from the sample are collected on a 2D-detector placed orthogonal to the incident 
beam. The raw scattering profile is transformed into a 1D curve of scattering intensity 
I(q) as a function of the scattering vector q, where q = 4π/λ (sin ), 2 is the scattering 
angle between the incident and the scattered vectors and  λ is the wavelength (Fig. 1.9A). 
The data are normalized based on the scattering intensity and the collection time. Finally, 
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the scattering of a buffer identical to the sample solvent is subtracted from the total 
scattering of the sample, providing the final scattering curve of the molecule in reciprocal 
space (Fig. 1.9B).  
Guinier analysis of the scattering curve at low scattering angle q is performed to 
determine the quality of the scattering data and if exposure of the sample to x-rays has 
induced radiation damage [69-70].  The linearity of a Guinier plot in the range of qRg ≤ 
1.3 for spherical proteins is indicative of a monodisperse sample that has not been 
affected by radiation damage. A non-linear dependence of the scattering curve suggests 
the presence of protein aggregation, improper background subtraction or that the sample 
may be elongated in shape.  
Additional structural parameters such as the radius of gyration (Rg), which is the 
mass distribution of the molecule around its center of gravity, and the molecular weight 
of the protein can be calculated based on the Guinier approximation. A linear fit of the 
scattering curve ln [I(q)] vs. q
2
 at the lowest q range, is used to extrapolate the Rg and the 
scattering intensity at q=0, or  I(0), used to calculate the molecular weight of the protein.  
Direct information about the shape and the degree of conformational dynamics of the 
molecule in solution can be obtained by calculating the Kratky plot (q
2
I(Iq) vs. q) from 
the scattering curve (Fig. 1.9D). Well folded spherical domains have a curve shaped like 
a parabola, whereas unstructured molecules lead to a profile that becomes linear at the 
high q values and does not return back to zero [69-70]. The presence of well folded 
domains linked by flexible linkers would produce a profile in between the two mentioned 
above.  
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Figure 1.9. SAXS data collection and analysis. A) Schematic of SAXS data collection. 
B). An example of scattering curve from TBL1(1-90). C) Examples of the correlation 
between the P(r) function and the shape of the molecules. D)  Kratky plot comparison 
of well folded and disordered proteins (adopted from Putnam, et. al., 2007). 
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Fourier transform of the scattering data generates the pair distribution function, 
P(r), which represents the distance distribution between the electrons in the molecule 
plotted as a function of the radius, r (Å), in real space. Structural parameters such as the 
maximum dimension of the molecule (Dmax) can be estimated from the P(r) function 
(Fig. 1.9C) [71]. The process of calculating the P(r) function is iterative and involves 
choosing multiple Dmax values, calculating the P(r) function and evaluating the curve for 
a smooth convergence to zero at the Dmax value [69-70].  
The P(r) function provides an estimate of the Rg in real space, which can be 
compared to the Rg from the Guinier analysis and used as a cross reference to confirm 
the validity of the analysis. There is a direct correlation between the shape of the P(r) 
curve and the shape of the molecule that can be very useful even in the absence of 
additional structural information. A domain with a spherical fold would have a bell 
shaped curve, whereas an elongated, rod-like domain would have a narrow peak with an 
extended shoulder (Fig. 1.9C). If the high resolution molecular structure is available, the 
Rg and Dmax values can be calculated based on the structure and used for direct 
comparison with the SAXS data. This analysis can provide important information about 
possible conformational changes of the molecule under different conditions.  
Critical advances in SAXS data processing have established new algorithms for 
generating low resolution ab initio models of the molecule from the scattering data. 
DAMMIN and GASBOR are the most commonly used programs for ab initio 3D 
modeling [72-73]. DAMMIN utilizes simulated annealing procedure to search for the 
best bead model that satisfies the low resolution scattering data. The ab initio model 
generated in GASBOR takes into account the higher resolution SAXS data as well. The 
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program uses a simulated annealing algorithm in fitting the model, where the protein is 
represented as dummy residues, into the scattering data from reciprocal space or the P(r) 
function in real space. The models from GASBOR and DAMMIN are finally 
superimposed and averaged using the program DAMAVER in order to obtain the most 
probable low resolution shape reconstruction represented as ensembles of identical 
dummy residues or beads [74].  
The most powerful application of SAXS data is when combined with high 
resolution structural information from x-ray crystallography, NMR or electron 
microscopy (EM) [70]. In the case where the structure of the protein has already been 
determine, the scattering profiles can be back-calculated. The goodness of the fit between 
the experimental and calculated scattering curves can be used for evaluating the models 
and for evaluating the presence of any conformational changes of the molecule.  
The study presented in this thesis work utilizes SAXS as a technique to determine 
the overall structural architecture of TBL1, which is an oligomeric, multi-domain 
scaffolding protein. The approach used was to perform a series of SAXS experiments on 
a number of different TBL1 fragments and the full-length protein. These results provided 
information about the spatial organization of the TBL1 domains. Since high resolution 
structures of TBL1 or any of the distinct domains are not available, the studies presented 
in chapter III uses crystal structures of homologous TBL1 domains to generate homology 
models for each of the TBL1 domains. These models have been fit into the final ab initio 
envelopes including a compendium model of the full length protein. 
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Experimental Overview 
The studies presented in this thesis work are composed of two distinct TBL1-
focused research areas, which characterize (i) the mechanism of β-catenin recruitment 
and ubiquitination by the Siah-mediated SCF
TBL1
-like complex and (ii) the structural 
architecture of TBL1 that provides insight into its role as a major scaffolding protein in 
the transcriptional regulation of NHRs. These studies have been performed with the 
scientific input of many generous collaborators.  
  Biochemical and functional approaches have been utilized to gain a deeper 
understanding of the mechanism of SCF
TBL1
-like-targeted ubiquitination of non-
phosphorylated β-catenin. Given the complexity of the multi-protein complex involved 
and the novelty of this E3 ligase, the molecular basis for the Siah-1-mediated 
ubiquitination of β-catenin was first investigated using an in vitro ubiquitination assay. 
Over-expression and purification protocols were developed for each of the SCF
TBL1
 
proteins including Skp1, Siah-1, SIP and the E2 conjugating enzyme UbcH5a. Insightful 
details for working on full length β-catenin and different truncation mutants were 
provided through the collaboration with Bill Weis (Stanford University). A transient 
expression system using mammalian 293-6E cells was used for the expression of full 
length TBL1 (FL-TBL1) with the support of the Vanderbilt protein expression core 
facility.  
Establishing an in vitro ubiquitination assay with purified proteins enabled a 
systematic analysis of β-catenin ubiquitination by the SCFTBL1-like complex (chapter II). 
Surprisingly, the in vitro experiments showed that Siah-1/UbcH5a alone is sufficient to 
poly-ubiquitinate β-catenin and TBL1 inhibits Siah-1-mediated ubiquitination of β-
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catenin. The direct physical interaction between Siah-1 and β-catenin was confirmed by 
nuclear magnetic resonance (NMR). The NMR chemical shift perturbation experiments 
proved especially powerful for studying dynamic interactions even in the case of these 
large, oligomeric proteins. To further characterize this novel pathway of targeting β-
catenin for ubiquitination we established a collaboration with David Friedman 
(Vanderbilt University), who utilized the mass spectrometry-based proteomics tools to 
elucidate the ubiquitin modified sites and the chain linkages assembled on β-catenin by 
Siah-1. 
The functional relevance of the biochemical data obtained in my studies was 
confirmed by experiments in the laboratory of Cun-Yu Wang (UCLA), using siRNA to 
knock down TBL1/TBLR1 and monitor their effect in cells during Wnt signaling. The 
data from the cell-based experiments demonstrates that TBL1 protects β-catenin from 
Siah-1-induced degradation during Wnt signaling. A model for the complex interplay 
between Siah-1-targeted degradation and TBL1-mediated protection of β-catenin was 
proposed (chapter II).  
The second part of my thesis work is focused on characterizing the structural 
architecture of TBL1 in order to gain insight into its role as a major scaffolding protein in 
transcriptional regulation. To begin our studies, a library of TBL1 truncation mutants that 
contain different tandem domains of the protein was established. We used size exclusion 
chromatography coupled  to multi-angle light scattering detectors (SEC-MALS) to obtain 
a direct readout for the molar mass of the proteins that is independent of their shape. The 
molar mass of FL-TBL1 corresponds well to a stable tetramer (chapter III). Biophysical 
experiments such as sedimentation velocity AUC in addition to SEC-MALS were 
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performed using TBL1 truncation mutants and identified the LisH as the core 
tetramerization domain of FL-TBL1. Site-directed mutagenesis with biochemical 
analyses were utilized to identify the precise residues at the LisH dimer of dimers 
interface.    
 Computational tools, Modeller and Rosetta, were used to generate homology 
models for each of the TBL1 domains and SAXS was utilized to generate a model for the 
FL-TBL1 tetramer (chapter III). SAXS is a powerful structural tool for characterizing the 
structure of large macromolecules and dynamic protein assemblies [70, 75]. The data 
were processed to obtain a low resolution ab initio model for the global architecture of 
FL-TBL1. The spatial organization of the TBL1 domains was deduced based on the ab 
initio models for the two shorter TBL1 constructs. The homology models for the domains 
were fitted in the SAXS model, bringing further insight into the binding region of 
different TBL1 substrates. 
  Finally, chapter IV provides a summary of the research and a proposed model for 
the role of TBL1 LisH-tetramer as the core unit of the scaffolding protein. Our results 
provide fundamental insights into the mechanism of TBL1 family members as major 
scaffolding proteins that serve in the transcriptional regulation of β-catenin and NHRs by 
mediating the precise switch between the multi-protein assemblies of activators and 
repressors. 
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CHAPTER II 
 
DIRECT UBIQUITINATION OF -CATENIN BY SIAH-1 AND REGULATION BY 
THE EXCHANGE FACTOR TBL1
1
  
 
Introduction 
β-Catenin is a ubiquitously expressed transcriptional activator in the canonical 
Wnt signaling pathway involved in cellular processes ranging from embryogenesis, cell 
proliferation, cell fate and survival to adult stem cell self-renewal and oncogenesis [40, 
76]. Upon Wnt stimulation, β-catenin binds to T cell factor/Lymphoid enhancer factors 
(Tcf)/(Lef) initiating the expression of many genes including cyclin D1, c-Myc, Axin2 and 
vascular endothelial growth factor (VEGF) [40]. Mutations in β-catenin and its 
regulatory factors, such as Adenomatous Polyposis Coli (APC), are associated with 
increased levels of nuclear β-catenin and in turn, to breast, colorectal, ovarian and other 
cancers [38, 40, 77].  
Not surprisingly, the level and cellular localization of β-catenin are tightly 
regulated by a finely tuned balance of post-translational modifications and protein 
turnover [40, 77]. The most efficient means to lower the cellular levels of β-catenin is by 
poly-ubiquitination, leading to degradation in the 26S proteasome. Defects in this protein 
degradation machinery or mutations in β-catenin that prevent the recognition or 
processing by this machinery often lead to the stabilization of β-catenin in its 
oncogenically active state [77]. 
                                               
1
 The bulk of this chapter was published in Dimitrova YN, Li J, Lee YT, Rios-Esteves J, Friedman DB, 
Choi HJ, Weis WI, Wang CY, Chazin WJ. (2010) Direct ubiquitination of β-catenin by Siah-1 and 
regulation by the exchange factor TBL1. J Biol.Chem. 285(18):13507-16. 
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Poly-ubiquitination involves the serial action of E1, E2 and E3 enzymes, of which 
the substrate-recruiting E3 ligating enzymes are the most diverse. β-Catenin is recognized 
and ubiquitinated by a growing number of E3 ligases. Of these, the most well-studied is 
SCF
β-TrCP
, a multi-protein complex that itself is regulated through the canonical Wnt 
signaling pathway [78-79]. In the absence of a Wnt ligand, β-catenin is phosphorylated 
by Glycogen synthase kinase-3β (GSK3β) and it is the phosphorylated state of the protein 
that is recognized by SCF
β-TrCP
. Under conditions of genotoxic stress, activation of p53 
occurs and an additional pathway for β-catenin degradation is initiated. p53 directly 
induces the expression of Siah-1 and in turn formation of a unique SCF-like complex 
SCF
TBL1
 comprised of Siah-1, Siah-1-interacting protein (SIP), Skp1, Transducin β-like 1 
(TBL1) and APC [13, 49]. The physiological significance of Siah-1-targeted degradation 
of β-catenin is underscored by the discovery that this pathway is directly targeted by the 
viral oncoprotein latent membrane protein 1 (LMP1) [80]. In addition, recent studies 
identified two drugs, hexachlorophene and isoreserpine, which attenuate the function of 
β-catenin through activation of Siah-1 and subsequent proteasomal degradation [81-82]. 
In addition to functioning as part of the SCF
TBL1
 complex, Siah-1 functions as an 
E3 ligase. The Siah-1 RING E2-binding domain is linked to a substrate binding domain 
that directly recruits, and mediates poly-ubiquitination of many substrates including 
Deleted in Colorectal Cancer (DCC), Nuclear Co-Repressor (NCoR), c-Myb and 
synphilin-1 [83-86]. The ability of Siah-1 to serve as a simple E3 ligase as well as a 
component of an SCF-like complex raises the possibility of redundancy in the poly-
ubiquitination pathways that lead to degradation of β-catenin. 
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The involvement of TBL1 in the SCF
TBL1
 E3 ligase complex is intriguing. Both 
TBL1 and its close isoform, TBL1-related protein (TBLR1) are exchange factors between 
nuclear co-activator and co-repressor complexes in the regulation of nuclear receptors 
and transcription factors [60]. Moreover, recent evidence shows that TBL1 acts as a co-
activator of the Wnt signaling pathway by recruiting β-catenin to the promoter of Wnt 
target genes and stimulating their expression [6]. Thus, TBL1 appears to play a role in 
both activation and repression of β-catenin activity. 
Previous studies by Matsuzawa and coworkers extensively characterized the 
ubiquitination of non-phosphorylated β-catenin through the action of SCFTBL1 in cells 
[13]. Here we report a combination of in vitro and cell based assays of β-catenin 
ubiquitination by SCF
TBL1
 and Siah-1 alone. Additionally, we mapped the physical 
interaction between Siah-1 and β-catenin and analyzed the effect of TBL1 on the Siah-1-
mediated ubiquitination of β-catenin. These results highlight the role of TBL1 as a 
protector of β-catenin activity during Wnt signaling.  
 
Results 
In vitro ubiquitination of β-catenin by the SCFTBL1 complex 
 In order to further investigate the molecular basis for β-catenin degradation by 
the SCF
TBL1
 complex, we developed an in vitro ubiquitination assay using purified 
recombinant proteins. The E2 conjugating enzyme UbcH5a, Skp1, Siah-1, SIP, and the β-
catenin substrate were overexpressed and purified from E. coli [87-89]. A transient 
expression system was used for the expression of full length TBL1 in mammalian 293-6E 
cells [90]. The protocols for the in vitro ubiquitination reaction were developed based on 
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previous reports [91], using proteins each purified to >95% homogeneity (Fig. 2.1A). In 
order to ensure that the full length β-catenin substrate is properly folded, a circular 
dichroism (CD) experiment was performed (Fig. A2.1). The analysis of this spectrum 
correlates well with the α-helical secondary structure elements observed in the x-ray 
crystal structure of the protein [92]. 
The ubiquitination reaction was initiated by addition of ATP after mixing all 
components and incubated for 60 minutes at 30 
o
C. Lane 5 in Figure 2.1B shows the 
 
FL-β-catenin + + - + + + + + +
E1/UbcH5a - + + + + + + + +
Ubiquitin - - + + + + + + +
Siah-1  - + + + + + + + -
TBL1 - + + + + - + + +
Skp1   - + + + + + - + +
SIP      - + + + + + + - +
ATP - + + - + + + + +
Time (min) 60 60 60 60 60 60 60 60 60
Lane 1 2 3 4 5 6 7 8 9
98
188kDa
β-catenin
β-catenin-(ub)n
188 kDa
98
62
49
38
28
17
14
6
3
A. B.
β-catenin
Siah-1
TBL1
SIP
Skp1
UbcH5a
ubiquitin E1
Figure 2.1. Reconstitution of the SCF
TBL1
-like E3 ligase in vitro. (A) Recombinantly 
expressed and purified proteins: β-catenin, His6-MBP-Siah-1, His6-TBL1, His6-SIP, 
His6-Skp1, His6-UbcH5a and ubiquitin (BostonBiochem) visualized by a Coomassie-
stained SDS-PAGE gel. (B) in vitro ubiquitination of FL-β-catenin with E1, E2-
UbcH5a, ubiquitin, Siah-1, SIP, Skp1, and TBL1. Upon activation with ATP the 
samples were incubated for 60 minutes at 30 
o
C. The reactions were stopped by the 
addition of SDS-Loading buffer and boiling for 15 minutes. The samples were resolved 
on a 4-12% gradient SDS-PAGE gel and visualized by Coomassie staining. Full scale 
Coomassie stained SDS-PAGE gel is shown in Supplementary materials Figure A2.2. 
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complete reaction with all components of the SCF
TBL1
 present. In this reaction, all free β-
catenin has been consumed, resulting in formation of a characteristic ubiquitin ladder. 
Control experiments show no ubiquitination of β-catenin when ubiquitin (lane 2), β-
catenin substrate (lane 3) or ATP (lane 4) are excluded from the reactions (Fig. 2.1B). 
The absence of Siah-1 also results in no discernable ubiquitination of β-catenin, 
presumably due to the inability to co-localize the E2-conjugated ubiquitin and the 
substrate (Fig. 2.1B, lane 9). In contrast, β-catenin poly-ubiquitination is observed even 
in the absence of TBL1, Skp1 or SIP (Fig. 2.1B, lanes 6-8). Together, these results show 
that the poly-ubiquitination of β-catenin by SCFTBL1 can be reconstituted in vitro and 
only Siah-1 is required for β-catenin poly-ubiquitination. 
 
Siah-1 directly ubiquitinates -catenin 
  The results from the in vitro ubiquitination of β-catenin by the SCFTBL1 complex 
were somewhat puzzling given the prevailing view of multi-protein SCF E3 complexes. 
Ideally, in the absence of any one component, the complex could not assemble and would 
lose its ubiquitinating activity. Our observation of β-catenin poly-ubiquitination in the 
absence of TBL1, Skp1 and SIP implied that non-phosphorylated β-catenin can be poly-
ubiquitinated by an alternate Siah-1 mediated mechanism. Motivated by reports that Siah-
1 serves as a simple E3 ligase and the observation that only Siah-1 is required for the 
ubiquitination of β-catenin (Fig. 2.1B, lane 9), a series of in vitro assays were performed 
to investigate if Siah-1 alone could serve as an E3 ligase for the β-catenin substrate and if 
so, was the reaction modulated by any of the other SCF
TBL1
 proteins.  
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FL-β-catenin + + + + + + + + + + -
E1/UbcH5a + + + + + + + + + - +
ubiquitin + + + + + + - + + - +
Siah-1 + + + + + + + - + - +
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98
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Commassie stained SDS-PAGE gel
98
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β-catenin
β-catenin-(ub)n
β-catenin
β-catenin-(ub)n
WB: β-catenin Ab
**
E1
A time-course of the ubiquitination reaction with Siah-1 alone as an E3 ligase is 
shown in Figure 2.2. Substantial mono-ubiquitination of β-catenin was observed within 
10 minutes of activation of the reaction and both the extent of ubiquitination and the 
number of added ubiquitins increase over time (lanes 2-6). No ubiquitination was 
Figure 2.2. In vitro ubiquitination of β-catenin by Siah-1 E3 ubiquitin ligase. The in 
vitro ubiquitination of β-catenin by Siah-1 was reconstituted in a 20 µl reaction using 
E1 (BostonBiochem), ubiquitin, E2-UbcH5a, His6-MBP-Siah-1 (0.1 µM) and β-
catenin-FL (0.3 µM). After the addition of ATP the samples were incubated at 30 oC 
for different time periods. The reactions were terminated with SDS-Loading buffer 
and boiling for 15 minutes. ¾ of the sample volume from each of the reactions was 
resolved on a 4-12% gradient SDS-PAGE gel and visualized by Coomassie staining 
(top panel). The same ubiquitination reaction was detected on a Western blot with β-
catenin antibody (Cell Signaling) using the remaining ¼ of the reaction (bottom 
panel). 
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observed in reactions lacking ubiquitin, Siah-1 or ATP (lanes 7-9). Siah-1 robustly auto-
ubiquitinates but as shown in lane 11, the auto-ubiquitination reaction in the absence of 
β-catenin does not result in the distinctive ladder that is observed in the presence of the 
substrate (cf. lanes 6 vs. 11). Immunoblotting with β-catenin antibody confirms that the 
species observed by coomassie staining correspond to modified β-catenin substrate (Fig. 
2.2, bottom panel). The specific pattern of two strong bands of ubiquitinated β-catenin 
seen in Figure 2.1 can arise from multiple mono-ubiquitination events. In order to 
confirm that β-catenin is poly-ubiquitinated we performed the in vitro ubiquitination 
reaction using K(0)-ubiquitin (Fig. A2.2B). This reaction shows a substantial overall 
decrease in the ladder of K(0)-ubiquitinated β-catenin compared to the ladder observed 
with wt-ubiquitin, confirming that β-catenin is indeed poly-ubiquitinated.  
The specificity of Siah-1 for β-catenin in the in vitro ubiquitination assay was 
confirmed using a substrate Skp1 that does not bind to Siah-1. Figure A2.2A shows that 
Skp1 is not ubiquitinated. To further demonstrate that Siah-1 ubiquitination requires 
physical interaction, the assay was performed using SIP, which is known to directly 
interact with Siah-1 [87]. As anticipated, SIP is efficiently poly-ubiquitinated by Siah-1 
(Fig. A2.2B). Thus Siah-1, acting on its own as an E3 ligase, specifically poly-
ubiquitinates β-catenin in vitro, in a phosphorylation-independent manner.  
 
Siah-1 forms K11 ubiquitin chains on -catenin 
 In order to determine the specific ubiquitin chain assembled on β-catenin by 
Siah-1, the ubiquitinated substrate was characterized by tandem mass spectrometry. The 
products from the standard in vitro ubiquitination reactions were resolved on an SDS-
42 
 
PAGE gel and the second band, labeled ** (Fig. 2.2, lane 6) was excised, subjected to in-
gel trypsin digest, followed by liquid chromatography-mass spectrometry (LC-MS/MS). 
The strategy involved identifying ubiquitin peptides from the trypsin proteolysis that 
contain lysine residues with the mass addition of 114.04 Da from the covalently attached 
ubiquitin signature peptide (-GG) that remains attached after trypsin cleavage. A single 
modified peptide sequence, K6TLTGK11-GGTITLEVEPSDTIENVK27A, from ubiquitin 
was identified indicating a Lys11 linked ubiquitin chain on β-catenin. A number of 
studies have already shown that formation of Lys11 ubiquitin chains can target the 
substrates for degradation in the cell [93-94]. These data indicate that Siah-1/UbcH5a 
alone can assemble Lys11-linked ubiquitin chains on β-catenin that could lead to the 
proteasomal degradation of β-catenin in cells.  
 
TBL1 inhibits in vitro poly-ubiquitination of β-catenin by Siah-1 
Direct physical and functional interaction between TBL1 and β-catenin is well 
established [6, 13]. TBL1 and its isoform, TBLR1, are required for the transcriptional 
activity of β-catenin in cells by mediating recruitment of β-catenin to the promoter of 
Tcf/Lef target genes during Wnt signaling [6]. Moreover, in the SCF
TBL1
 complex, TBL1 
plays the role of directly binding and recruiting non-phosphorylated β-catenin to the 
complex [13]. However, our in vitro ubiquitination data indicate that the presence of 
TBL1 is not required for the recruitment and poly-ubiquitination of β-catenin by Siah-1. 
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In order to obtain further insights into these observations, we compared Siah-1 in 
vitro ubiquitination assays performed under identical conditions for β-catenin alone and 
pre-incubated with SCF
TBL1
 (Fig. 2.3). In order to specifically monitor ubiquitination of 
β-catenin, the reactions were detected by Western blot with β-catenin antibody [95]. We 
noted that although species with long poly-ubiquitin chains are indeed generated in the 
reaction (Fig. 2.2), the amount of highly poly-ubiquitinated β-catenin molecules is below 
the detection limit and only the first few bands are observed using this approach. 
 
FL-β-catenin + + + + + + + + + + + + + + + +
E1/UbcH5a + + + + + + + + + + + + + + + +
ubiquitin + + + + + + + + + + + + + + + +
Siah-1    + + + + + + + + + + + + + + + +
TBL1 - - - - - - + + + + + + + + + +
SIP , Skp1 - - - - - - + + + + + - - - - -
ATP - + + + + + + + + + + + + + + +
Time (min) 60 5 10 15 30 60 5 10 15 30 60 5 10 15 30 60
Lane 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
β-cat
β-cat-(ub)n
WB: β-catenin Ab
Figure 2.3. TBL1 inhibits Siah-1-mediated poly-ubiquitination of β-catenin. The in 
vitro ubiquitination assay was performed with E1, E2, ubiquitin and Siah-1. The 
substrate β-catenin was pre-incubated with SCFTBL1 or TBL1 for 30 minutes at RT 
before the rest of the ubiquitination components were added. The reactions was 
activated by the addition of ATP and incubated at 30 
o
C for different time periods. The 
reactions were resolved on an SDS-PAGE gel and detected on a Western blot with β-
catenin antibody (Cell Signaling). Full scale Coomassie stained SDS-PAGE gel is 
shown in Figure A2.4.  
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Interestingly, Siah-1 alone appeared to ubiquitinate β-catenin at a faster rate than 
the SCF
TBL1
 complex. Figure 2.3 presents a time-course of β-catenin ubiquitination by 
Siah-1 in the absence (lanes 2-6) and presence (lanes 7-11) of SCF
TBL1
.  Free β-catenin 
was depleted by 60 min in the absence of SCF
TBL1
, whereas a significant amount of non-
ubiquitinated β-catenin still remained when TBL1 was present in the reaction (Fig. 2.3, 
lanes 6 vs. lane 11). Furthermore, mono-ubiquitination of β-catenin by Siah-1 alone was 
observed at the 5 minute point, and two additional bands of ubiquitinated β-catenin also 
appear at 10 and 15 min (lanes 2-4). In contrast, only one band of ubiquitinated β-catenin 
was observed at 15 min after pre-incubation with SCF
TBL1
 (lane 9). This clearly shows 
that the formation of ubiquitin chains on β-catenin is delayed in the presence of all 
SCF
TBL1
 proteins. Since the differences between the time courses are modest, the 
experiments were repeated several times, including using proteins from different 
purification stocks. A high reproducibility was observed between experiments, which 
validates the observations.  
To further investigate if a single component from the SCF
TBL1
 is able to attenuate 
Siah-1-dependent ubiquitination of β-catenin, the effect of pre-incubating SIP, Skp1 or 
TBL1 with β-catenin was tested. Lanes 12-16 in Figure 2.3 show that the addition of 
TBL1 alone had an effect similar to the SCF
TBL1
 complex (lanes 7-11). Together, these 
results show that TBL1 inhibits the in vitro poly-ubiquitination of β-catenin by Siah-1.  
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Figure 2.4. TBL1/R1 protects -catenin from Siah-1-mediated poly-ubiquitination and 
subsequent degradation in vivo. TBL1 and TBLR1 were knocked down in 293T cells 
with siRNA. 24 hours later the cells were transfected with Siah-1 and treated with 20 
mM LiCl. (A)  β-catenin levels were detected in the nuclear fraction by 
immunoblotting. The panels on the left are with transient expression of Siah-1 and on 
the right are without expression of Siah-1. The levels of transfected Siah-1 in the 
whole cell extract is shown in the bottom two panels. (B) Detection of β-catenin levels 
in the cytoplasmic fraction of the cell.  
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TBL1 inhibits Siah-1-mediated β-catenin degradation in cells 
Expression of Siah-1 had been correlated with reduced levels of β-catenin in cells 
[13, 49, 80, 96]. Overexpression of Siah-1 in the absence of a Wnt ligand reduced levels 
of β-catenin and lowered the induction of Tcf/Lef-target genes [13, 49]. Wnt activation 
also stimulated the interaction of TBL1 and TBLR1 with β-catenin [6]. In the presence of 
a Wnt ligand, expression of Siah-1 also decreased the amount of expressed Tcf/Lef-target 
genes, promoting the degradation of β-catenin, but the effect was not as substantial as in 
the absence of a Wnt ligand [49]. 
To determine the effect of TBL1/TBLR1 on β-catenin degradation during Wnt 
signaling we examined the levels of β-catenin in cells. It is important to note that the 
endogenous level of Siah-1 in cells is extremely low and does not rise to appreciable 
levels until p53 is activated. Thus, endogenous Siah-1 cannot ordinarily be observed on 
western blots. In essence, because Siah-1 is not prevalent in quiescent cells, the "normal" 
condition when Siah-1 is actively involved in regulating β-catenin corresponds only when 
there is stress to the cells so that Siah-1 is upregulated through activation of p53. 
Consequently, the standard and now well-accepted approach to study the effects of Siah-
1 is via overexpression [13, 49, 83-86]. In order to study the roles of non-canonical 
pathways for β-catenin degradation, the basal phosphorylation-dependent poly-
ubiquitination of β-catenin by the SCFβTrCP complex must be down regulated. The 
standard protocol for this is to use LiCl to inhibit GSK-3β kinase, which suppresses the 
phosphorylation of β-catenin and therefore its ability to be recognized and degraded by 
the SCF
βTrCP 
complex [6, 38]. 
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In our experiments, small interfering RNA (siRNA) was used to knock down the 
expression of TBL1 and TBLR1 in HEK293T cells, and LiCl was added after 
transfection of Siah-1 to monitor the effect on degradation of β-catenin. The amount of 
nuclear and cytoplasmic β-catenin was detected over a period of time by Western blot 
analysis. More than 80% reduction of TBL1 and TBLR1 expression was achieved in 
293T cells by the siRNA (Fig. 2.4A, bottom panels). Expression of Siah-1 led to a 
significant decrease in the level of nuclear β-catenin over the time course of Wnt 
induction when TBL1 and TBLR1 were knocked down. In contrast, the presence of 
TBL1 and TBLR1 was seen to protect β-catenin from Siah-1-mediated degradation in the 
nucleus (Fig. 2.4A). The same effect was observed with cytoplasmic β-catenin, where a 
significant decrease in the level of β-catenin was seen when TBL1 and TBLR1 are 
knocked down (Fig. 2.4B).  
In order to ensure that the level of transfected Siah-1 was comparable to 
previously published data and to the amount of protein expressed upon activation of p53 
during DNA damage, we measured the level of Siah-1 after transfection and upon 
addition of adriamycin [13, 49, 97]. Our transfection protocol did not result in gross 
overexpression of Siah-1, and in fact the level of Siah-1 was similar to the level observed 
upon activation of p53 (Fig. A2.5). Taken together, our results indicate that upon Wnt 
signaling, TBL1 and TBLR1 serve to protect β-catenin from Siah-1-induced degradation.  
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Siah-1 ubiquitinates β-catenin at lysines outside the TBL1 binding site 
The core of β-catenin is an armadillo (arm) repeat domain, which has an 
elongated α-helical structure that facilitates the interaction of the majority of β-catenin 
substrates [89, 92]. The interaction site of TBL1 with β-catenin was previously mapped 
to the N-terminal region of this (arm) domain, specifically residues 134-467 [6]. In order 
to test if TBL1 directly blocks access to the lysine residues targeted for ubiquitination by 
Siah-1, mass spectrometry was used to identify the ubiquitination sites on β-catenin [29, 
98]. The standard in vitro ubiquitination reaction was carried out and the reaction 
 
FL-β-catenin + +
E1/UbcH5a - +
ubiquitin - +
Siah-1 - +
ATP - +
Time (min) 90 90
Lane # 1 2
98
62
49
1
2
Protein Residues Peptide sequence Bands
β-catenin
662-671 R.MSEDK666PQDYK.K 1, 2
666-672 R.MSEDKPQDYK671K.R 1, 2
A.
B.
C.
188kDa
Figure 2.5. Siah-1 poly-ubiquitinates -catenin on Lysines 666 and 671. (A) The in vitro 
ubiquitination assay was performed using recombinantly produced proteins as explained 
above. The reactions were resolved on an SDS-PAGE and stained with Coomassie blue. 
Bands 1 and 2 from lane 2 were excised from the gel, subjected to trypsin digestion and 
analyzed by liquid chromatography-mass spectrometry (LC-MS/MS). (B) Summary of the 
peptides identified from β-catenin and ubiquitin in each of the analyzed bands shown in 
A. The specific Lysine residues modified with the –GG signature peptide from ubiquitin 
is shown in bold. (C) Schematic presentation of β-catenin domains indicating the position 
of Lys666 and Lys671 ubiquitinated by Siah-1 and previously mapped TBL1 and Siah-1 
binding sites.  
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products were run on an SDS-PAGE gel (Fig. 2.5A). Bands 1 and 2 were excised, 
digested by trypsin and analyzed by LC-MS/MS. Lys666 or Lys671 at the C-terminal 
(Ct) domain of β-catenin (Ct: residues 665-781) were identified as the predominant sites 
of ubiquitination in both bands 1 and 2 (Fig. 2.5B). Notably, in all of the MS/MS 
experiments performed, no peptides with both Lys residues ubiquitinated were ever 
observed. Together, these data show the lysine residues on β-catenin targeted for poly-
ubiquitination by Siah-1 are well outside the TBL1 binding site (Fig. 2.5C).  
 
Siah-1 binds at the β-catenin armadillo domain  
The ability of TBL1 to protect β-catenin from ubiquitination by Siah-1 suggests 
there may be direct competition between TBL1 and Siah-1 for β-catenin. Since the TBL1 
binding site on β-catenin has been mapped to (arm) domain residues 134-467 [6], we set 
out to characterize the β-catenin binding site for Siah-1 using the in vitro ubiquitination 
assay. A series of experiments were performed on β-catenin-full length (FL) and 
truncation mutants containing the: N-terminal (Nt:1-133), Nt + armadillo repeat 
(Nt+arm:1-671), arm + C-terminal (arm+Ct:134-781) and (arm:134-671) domain. Poly-
ubiquitination of β-catenin was observed only for (Nt+arm), (arm+Ct) and the isolated 
(arm) domain. These observations indicate the (arm) domain is necessary and sufficient 
for Siah-1 recruitment and ubiquitination (Fig. 2.6A, B).  
An NMR chemical shift perturbation experiment was performed to confirm the 
direct physical interaction between Siah-1 and β-catenin. An 15N-enriched sample of 
Siah-1 Substrate Binding Domain (SBD) was purified and used to acquire 
15
N-
 1
H 
TROSY-HSQC spectra in the absence and presence of unlabeled β-catenin-FL protein.  
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β-catenin FL (Nt+arm) (arm+Ct) (arm) (Nt)
E1/UbcH5 - + + - + + - + + - + + - + +
ubiquitin - + + - + + - + + - + + - + +
Siah-1 - + + - + + - + + - + + - + +
ATP - - + - - + - - + - - + - - +
Lane # 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
A.
C.B.
98
62
49
38
28
17
14
Figure 2.6. The armadillo (arm) repeat domain of β-catenin is necessary and 
sufficient for binding and poly-ubiquitination by Siah-1. (A) Schematic diagram of 
β-catenin single and tandem domains tested for Siah-1 poly-ubiquitination in (B) by 
in vitro ubiquitination assay and a summary of the ubiquitination results for each of 
the constructs tested. (B) The in vitro ubiquitination assay was performed with 
purified recombinant β-catenin FL, (Nt+arm), (arm+Ct), (Ct) and (Nt) domain as a 
substrate in addition to the ubiquitination machinery: E1, E2, Siah-1, ubiquitin and 
ATP. The ubiquitination reaction is visualized by Coomassie blue. (C) 
15
N-
1
H 
NMR chemical shift perturbation assay confirming the interaction between Siah-1 
and β-catenin. Overlay of TROSY-HSQC spectra of 15N-labeled Siah-SBD (90-
282) acquired in the absence (gray) and presence (red) of β-catenin-FL. The 
experiment was collected at pH 8 and 30 
o
C with 
15
N-Siah-SBD at 122 µM, and β-
catenin added to 91.5 µM.  
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Binding of the 
15
N-Siah-SBD as a dimer of 44 kDa to the 85.5 kDa β-catenin would 
result in a complex larger than 100 kDa, which ordinarily would lead to slow tumbling 
times in solution and near complete loss of signal intensity. In such solutions, useful 
information on binding can be obtained when examining the early part of the titration 
curve for systems that exhibit binding in the µM range [67-68]. Upon addition of a sub-
stoichiometric amount of β-catenin to 15N-Siah-SBD, spectral changes were observed 
including loss of intensity and perturbation of chemical shifts for a subset of peaks in the 
spectrum (Fig. 2.6C and for full spectrum: Fig. A2.6). These observations confirm a 
relatively weak, but specific interaction between Siah-1 and β-catenin.  
 
Discussion 
Efficient poly-ubiquitination and degradation of β-catenin during genotoxic stress 
is critical to preventing constitutive cell proliferation and preserving genomic stability. 
Upon UV-induced DNA damage, β-catenin is targeted for poly-ubiquitination and 
subsequent proteasomal degradation by a p53-induced mechanism that does not require 
phosphorylation of the substrate [13, 49]. The critical protein in this pathway is Siah-1, 
which mediates an efficient depletion of β-catenin, thereby down regulating transcription 
of Wnt target genes. Siah-1-mediated degradation of β-catenin was initially demonstrated 
through the formation of an SCF-like complex (SCF
TBL1
), comprised of Siah-1, SIP, 
Skp1 and TBL1 [13]. We established an in vitro ubiquitination assay with reconstituted 
SCF
TBL1
 to investigate the mechanism of action of this complex, but interestingly we 
found that Siah-1 alone functions as an E3 ligase that is able to directly bind and poly-
ubiquitinate β-catenin in vitro (Fig. 2.2 and 2.6C). 
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In addition to demonstrating that poly-ubiquitination of β-catenin can occur 
through a direct interaction with Siah-1, we established that Siah-1/UbcH5 assembles 
Lys11 ubiquitin chains at a novel β-catenin ubiquitination site. We have also found that 
during Wnt signaling TBL1, a transcriptional co-activator of β-catenin, plays a role in 
protecting β-catenin from Siah-1-mediated poly-ubiquitination and proteasomal 
degradation. TBL1 and Siah-1 were found to bind β-catenin at the (arm) domain. The 
absence of poly-ubiquitination of TBL1 by Siah-1 in the in vitro ubiquitination assay 
(Fig. A2.2A) rules out the possibility of TBL1 competing with β-catenin as a substrate 
for Siah-1. While inhibition of β-catenin ubiquitination via an allosteric binding effect 
cannot be ruled out, our results support a model in which TBL1 protection of β-catenin 
from poly-ubiquitination by Siah-1 is due to direct competition for the Siah-1 binding 
site. 
 
The function of TBL1 as transcriptional co-activator and co-repressor of β-catenin 
TBL1 appears to serve two roles in regulating the activity of β-catenin. Besides 
the initially identified role of TBL1 in recruiting β-catenin to the SCFTBL1 complex, it has 
also been shown to function as a transcriptional co-activator of β-catenin in recruiting it 
to the promoter site of Wnt-target genes (left side Fig. 2.7) [6]. Our results indicated that 
TBL1 can inhibit the poly-ubiquitination of β-catenin by Siah-1 in vitro (Fig. 2.3) and 
stabilize β-catenin in cells by protecting it from Siah-1-mediated ubiquitination and 
proteasomal degradation (Fig. 2.4). 
We note that the in vitro ubiquitination of β-catenin by Siah-1 is not an extremely 
efficient reaction. APC is required to observe Siah-1-mediated degradation of β-catenin 
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in cells and that APC directly interacts with Siah-1 and with β-catenin [49, 99]. Our data 
indicates that Siah-1 binding to β-catenin is very dynamic and weak (Fig. 2.6C). It is 
likely that APC serves as a molecular bridge for Siah-1 and β-catenin, thus stabilizing the 
complex to increase the efficiency of ubiquitin chain formation in cells. The situation in 
cells would also be different because TBL1 recruits β-catenin to the Tcf/Lef transcription 
factors, which in effect protects β-catenin from access by Siah-1.  This interpretation is 
supported by the inhibitory effect of TBL1 in the cell based experiments (Fig. 2.4). 
Furthermore, our data indicates that TBL1 (TBLR1) forms a complex with β-catenin in 
the cytoplasm and nucleus, since β-catenin can be protected from Siah-1 induced 
degradation in both cellular compartments (Fig. 2.4). Together, our results suggest a 
model in which down regulation of Wnt target genes during DNA damage involves 
binding of β-catenin by Siah-1 and poly-ubiquitination of TBL1-unboud, non-
phosphorylated β-catenin (Fig. 2.7). Once a complex between β-catenin and TBL1 
(TBR1) is formed upon Wnt stimulation, it binds the Wnt-target gene promoter and 
transcription factors such as Tcf, therefore limiting the ability of Siah-1 to access and 
poly-ubiquitinate β-catenin. We propose that the activation of Wnt-target genes during 
genotoxic stress and the regulation of cellular processes such as cell proliferation and 
apoptosis depend on the balance of Siah-1-mediated degradation of β-catenin versus 
TBL1 (TBLR1)-facilitated protection and activation of β-catenin targeted genes.  
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Figure 2.7. Model of the mechanism of TBL1-mediated activation and Siah-1-induced 
poly-ubiquitination of -catenin. (A) During Wnt activation, the degradation of β-catenin 
is inhibited leading to its accumulation in the cytoplasm and translocation to the nucleus. 
TBL1/TBLR1 form a complex with β-catenin and mutually co-localize to the promoter 
site of Wnt-target genes, stimulating their transcription. (B) Upon DNA damage during 
Wnt signaling, Siah-1 targets free β-catenin in the cytoplasm and nucleus for poly-
ubiquitination and proteasomal degradation, resulting in down regulation of Wnt-target 
gene transcription. 
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The role of SCF
TBL1
 components SIP and Skp1 on β-catenin poly-ubiquitination and 
degradation 
 Our results leave open the question as to whether Siah-1 is sufficient for the 
recruitment and poly-ubiquitination of β-catenin in cells or additional components from 
the SCF
TBL1
 complex are necessary. Siah-1 has a substrate binding domain for recruiting 
substrates and a RING domain for binding the E2-ubiquitin complex. It has been shown 
to act alone in poly-ubiquitinating many substrates such as DCC, NCoR and synphilin-1 
[83-84, 86]. Our data also indicates that Siah-1 can function as a simple E3 ligase for 
poly-ubiquitination of β-catenin. If Siah-1 functions on its own, what is the role of SIP? 
One possibility is that SIP, like DCC and NCoR, is simply another target of Siah-1 for 
poly-ubiquitination and degradation. In vitro ubiquitination reactions show an efficient 
poly-ubiquitination of SIP in the presence or absence of Skp1, TBL1 and β-catenin (Fig. 
A2.2B). Over-expression of SIP mutants that cannot interact with Siah-1 prevented the 
efficient degradation of β-catenin in HEK293T cells and the level of SIP was essential for 
β-catenin degradation in gastric and renal cancer cells [100-102]. However, 
overexpression of only Siah-1 was sufficient for β-catenin degradation in cells and the in 
vitro ubiquitination of β-catenin was not affected by the addition of SIP (Fig. 2.4 and 
A2.3B) [49, 80]. It is possible that the interaction between SIP and Siah-1 is important for 
the proper localization of Siah-1 or for protection of Siah-1 from auto-ubiquitination and 
degradation. 
The role of Skp1 as an adaptor is to provide an anchor in SCF ligases between 
Cullins, in our case SIP, and the F Box–protein TBL1. Interaction between SIP and Skp1 
has been demonstrated by affinity chromatography and NMR chemical shift perturbation 
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experiments [87]. However, evidence for an effective interaction between the F Box 
domain of TBL1 and Skp1 is lacking. A wealth of biochemical and structural data have 
established that the binding between Skp1 and F Box domains from Skp2 or β-TrCP is 
very strong with a half-life of the Skp1-Skp2 complex  longer than 9 hours and the 
surface area of the core interface of more than 2000Å
2
  [103-104]. TBL1 has a putative F 
Box domain that appears to have a very low affinity for Skp1. Previous studies using the 
Drosophila homologue of TBL1, Ebi have been unsuccessful to detect an interaction 
between Ebi and Skp1 [105]. We have also been unable to detect this interaction by pull 
down experiments with purified proteins, co-expression of Skp1 and TBL1 followed by 
pull downs and negative gel shift assays. Using the very sensitive NMR chemical shift 
perturbation assay, we found an extremely weak (KD ~mM) interaction between Skp1 
and TBL1 (1-170) (Fig. A2.7). Thus, it is unclear how Skp1 is able to play the role of the 
adaptor in the SCF
TBL1
 complex. Although additional experiments are required to 
systematically evaluate if the SCF
TBL1
 does indeed form in vivo as postulated, the role of 
Siah-1 in degradation of β-catenin and the modulation of this activity by TBL1 are clear.   
The SCF
TBL1
 complex closely resembles the Drosophila Sina/Phyl/Ebi complex. 
In Drosophila, the transcriptional repressor Ttk88 is recruited and poly-ubiquitinated by 
the Sina (Siah-1 homologue)/Phyllopod (Phyl) complex for proteasomal degradation 
[12]. Phyl functions as an adaptor of Sina in recruiting different substrates for poly-
ubiquitination during Drosophila neurogenesis [106]. Both Phyl and mammalian SIP 
contain a Siah-binding motif or a degron sequence that has been crystallized in complex 
with Siah-SBD, demonstrating an almost identical interaction [107]. Ttk88 can directly 
bind to Sina and Phyl, but it also requires Ebi (a homologue of TBL1) for an efficient 
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poly-ubiquitination and degradation of Ttk88. In contrast to TBL1, which directly binds 
β-catenin, Ebi has a strong affinity for Sina and Phyl, but weak and indirect interaction 
with the substrate Ttk88 [105]. The similarity between mammalian and Drosophila 
Siah/Sina-mediated ubiquitin complexes suggests the formation of a Siah-1-mediated E3 
ligase that does not resemble the conventional SCF complex. Siah-1 and Sina can directly 
bind and recruit the substrate for poly-ubiquitination, but they also require the assistance 
of the adaptor protein SIP/Phyl. Skp1 has been demonstrated to be dispensable to the 
function of the complex by us and others [105]. Most interestingly Ebi does not interact 
directly with the Ttk88 substrate, but with Sina and Phyl, whereas TBL1 appears to play 
a dual role in facilitating both activation and degradation of protein substrates.  
 
Tight regulation of β-catenin by multiple E3 ligases 
The existence of multiple ubiquitination pathways leading to degradation implies 
the physiological importance of tightly regulating β-catenin. Besides the major E3 ligases 
SCF
β-TrCP
 and the p53-induced Siah-1, poly-ubiquitination of β-catenin is also initiated by 
a recently identified single subunit E3 ligase, Jade-1 [108]. Interestingly, membrane-
associated β-catenin is regulated by a different set of E3 ligases, such as Hakai and the 
muscle specific Ozz E3 ubiquitin ligase [109-110]. Thus the mechanism of recognition, 
recruitment and poly-ubiquitination of β-catenin by different E3 ligases as well as the 
signaling event initiating the degradation of the substrate appears to vary substantially. 
The activation of the SCF
β-TrCP
 depends on the presence or absence of a Wnt ligand, 
whereas Siah-1 mediated β-catenin degradation is induced by activation of p53 during 
genotoxic stress. In the SCF
β-TrCP
 complex, β-TrCP binds the phosphorylated N-terminal 
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domain of β-catenin leading to the attachment of ubiquitin chains on Lys19 and Lys49 [1, 
48]. Here, we show that Siah-1 binds the non-phosphorylated β-catenin, leading to the 
attachment of ubiquitin chains at the very C-terminal region of the (arm) domain on 
Lys666 and Lys671. Notably, this coincides with the binding surface of most 
transcription co-activator complexes such as p300/CBP and TRRAP/TIP60 histone 
acetyltransferaces (HATs) and the PAF1 complex [39]. Thus poly-ubiquitination of β-
catenin by Siah-1 could prevent the transcription of many Wnt target genes. Mutations in 
β-catenin can lead to inefficient degradation and therefore greater accumulation in the 
nucleus. The corresponding over activation of Tcf/Lef genes by β-catenin is believed to 
be responsible for the initiation and progression of many types of cancer [38]. 
Understanding the uniqueness and precise mechanism of action of each E3 ubiquitin 
ligase targeting β-catenin for degradation and the molecular basis for defective activity of 
mutants is an important goal for understanding the accumulation of β-catenin in the cell 
and its relationship to oncogenesis. 
 
Experimental Procedures 
Bacterial protein expression and purification 
 Full length Siah-1 (residues 1-282) was expressed as a His6-maltose binding 
protein (MBP)-fusion protein. The human cDNA was sub-cloned in pLM302 plasmid 
(Laura Mizoue, Center for Structural Biology, Vanderbilt University), which contained a 
3C-precision protease cleavage site after the MBP tag. The SBD of Siah-1, (residues 90-
282) was sub-cloned in a pET28a vector (Novagen) with an N-terminal His6-tag 
containing a thrombin cleavage site. SIP and Skp1 were expressed as His6-constructs 
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from pET28a vectors as previously described [87]. UbcH5a was expressed as a His6-
fusion construct in a pET15 vector. Full length murine β-catenin (residues 1-781) and 
four truncation mutant constructs (Nt: residues 1-133), (Nt+arm: residues 1-671), (arm: 
residues 134-671) and (arm+Ct: residues 1-781) were expressed as glutathione S-
transferase (GST)-fusion proteins from pGEX vectors as previously described [89].  
The proteins were overexpressed in the Escherichia Coli BL21(DE3) strain. Cells 
were grown at 37 
o
C until they reached  A600 of 0.6-0.8 and were then induced with 0.5 
mM isopropyl thiogalactoside (IPTG) for 3-4 hours at 25 
o
C for Siah-1 constructs, 30 
o
C 
for β-catenin constructs and 37 oC for SIP, Skp1 and UbcH5a. Purification of Siah-1, SIP, 
Skp1 and UbcH5a was performed by Ni-NTA (Qiagen) followed by a Source Q 
chromatography [87, 111]. Expression of 
15
N-labeled Siah-SBD was carried in minimal 
medium supplemented with 
15
NH4Cl as the sole nitrogen source following the same 
protocol. β-catenin constructs were affinity purified on Glutathione Sepharose 4B 
(Amersham) followed by cleavage of the GST-fusion tag, Source Q and size exclusion 
chromatography, as previously described [89].  
 
Recombinant expression of TBL1 in mammalian 293-6E cells 
 Full length murine TBL1 (residues 1-526) was sub-cloned into pTT5 vector used 
for intracellular expression of proteins in mammalian 293 cells [90]. N-terminal His6-tag 
followed by a 3C-precision protease cleavage site was cloned into the XbaI/EcoRI site of 
pTT5. Then the TBL1 cDNA was inserted into the EcoRI/NotI site of pTT5. Human 
Embryonic Kidney (HEK) 293-6E cells (Invitrogen) with stably expressing Ebstein-Barr 
virus nuclear antigen 1 (EBNA1) were grown in suspension in low-calcium-hybridoma 
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serum-free medium (HSFM), under standard conditions at 37 
o
C and 5% CO2, 
supplemented with 1% bovine calf serum (BCS), 50 µg ml
-1
 Genericin, 0.1% Pluronic F-
68 (Sigma) and 10 mM HEPES [90]. The cells were resuspended in fresh HSFM medium 
with 1% BCS at a density of 1.0 x 10
6
 cells ml
-1 
three hours before transfection. TBL1 
was transfected using linear Polyethylenimine (PEI) (Aldrich) into 300 ml of 293-6E 
cells. 48 hours post transfection, the cell pellet is harvested and stored at -20 
o
C.  
Recombinant His6-TBL1 was affinity purified on a Ni-NTA resin using 25 mM 
Tris-Cl, pH 7.5, 300 mM NaCl, 5 mM Imidazole, 5 mM β-Mercapto Ethanol (βME) as 
NiA buffer and 300 mM Imidazole in the NiB buffer. The final yield of purified TBL1 
from 293-6E cells is between 4-6 mg/L.  
 
In vitro ubiquitination assay of FL-β-catenin 
All ubiquitination experiments were carried out at a final volume of 20 µl 
including: E1(BostonBiochem) at 52 nM, His6-E2-UbcH5a at 0.6 µM, ubiquitin 
(BostonBiochem) at 50 µM, His6-MBP-Siah-1 at 0.18 µM, SIP at 1.5 µM, Skp1 at 1.5 
µM, and His6-TBL1 at 1.5 µM. The assay was performed in ubiquitination buffer 
containing 100 mM NaCl, 1 mM DTT, 5 mM MgCl2 and 25 mM Tris-Cl, pH 7.5 for 0.25 
µM β-catenin-FL and (Nt) domain or at pH 8, for β-catenin (arm) and (arm+Ct) 
constructs. The reactions were activated with 5 mM ATP and incubated for different time 
periods, as indicated on the specific experiments, at 30 
o
C. To stop the ubiquitination 
reaction, the samples were incubated for 15 minutes at 90 
o
C after the addition of 5 µl 
SDS-Loading buffer. Reactions were resolved on a NuPAGE 4-12% Bis-Tris gradient gel 
(Invitrogen) and detected by a SimplyBlue SafeStain (Invitrogen). Ubiquitination 
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reactions analyzed by Western blotting using C-terminal β-catenin primary antibody (Cell 
Signaling) and visualized with goat anti-rabbit-horseradish peroxidase (HRP) by 
SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific).    
 
NMR samples and chemical shift perturbation assay 
 
15
N-
 1
H TROSY HSQC spectra were acquired for 
15
N-enriched Siah-SBD at 122 
µM in 25 mM Tris-Cl, pH 8, 100 mM NaCl and 10 mM βME in 90% H2O/ 10% D2O. 
One sample was free Siah-SBD and the second also contained 91.5 µM unlabeled β-
catenin-FL. The NMR experiments were performed using a Bruker DRX 800 MHz 
spectrometer equipped with a CryoProbe. The 
15
N-
1
H TROSY HSQC spectra were 
acquired at 303 K with 128 scans. Data were processed using Topspin 2.0b (Bruker) and 
analyzed with Sparky [81].   
 
Mapping ubiquitination sites on β-catenin and ubiquitin chain formation by mass 
spectrometry analysis 
 Proteins were separated by SDS-PAGE and the gel was stained with SimplyBlue 
SafeStain (Invitrogen).  Individual protein bands were excised, equilibrated in 50 mM 
NH4HCO3, reduced with DTT (3 mM in 100 mM NH4HCO3, 37 °C for 15 min) and 
alkylated with iodoacetamide (6 mM in 50 mM NH4HCO3 for 15 min).  The gel slice was 
then dehydrated with acetonitrile and rehydrated with 15 µL 12.5 mM NH4HCO3 
containing 0.01 µg/µL modified trypsin (Promega), and trypsin digestion was carried out 
for >2 hours at 37 °C.  Peptides were extracted with 60% acetonitrile, 0.1% 
trifluoroacetic acid, and dried by vacuum centrifugation and resuspended in 10 µL 0.1% 
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formic acid. LC-MS/MS analysis of the peptides was performed using a Thermo LTQ ion 
trap mass spectrometer equipped with a Thermo MicroAS autosampler and Thermo 
Surveyor HPLC pump, Nanospray source, and Xcalibur 2.0 SR2 instrument control. The 
peptides were resolved on a fused silica capillary column, 100 µm × 15 cm, packed with 
C18 resin (Jupiter C18, 5 µm, 300 Å, Phenomonex, Torrance, CA)  using a 95 min 
gradient of increasing acetonitrile with 0.1% formic acid.  MS/MS scans were acquired 
using an isolation width of 2 m/z, and activation time of 30 ms, activation Q of 0.250, and 
35% normalized collision energy using 1 microscan and maximum injection time of 100 
for each scan.  The MS/MS spectra of the peptides were acquired using data-dependent 
scanning (top-five) with dynamic exclusion (60 sec exclusion, list size = 50, repeat count 
= 1).  Individual MS/MS fragmentation spectra were then searched against the IPI_mouse 
database (Feb 2008) allowing for complete carbamidomethylation of cysteine, and partial 
modification by oxidation of methionine.  Partial modification of lysine by +114 Da was 
also selected to detect ubiquitinated peptides (mass shift due to GG ubiquitin sequence 
that remains after trypsin digestion).  All candidate spectra were manually inspected for 
verification of ubiquitination. 
 
Cell culture, siRNA transfection and Western blot analysis 
 Human embryonic kidney 293T cells were cultured in DMEM media containing 
10% FBS at 37°C in a 5% CO2/ 95% air atmosphere. For siRNA transfections, 1 × 10
6
 
293T cells were seeded into 6-well plates for 12 hours and then transfected with various 
amount of siRNA using Lipofectamine 2000 according to the manufacturer’s protocol 
(Invitrogen). Expression vector of Flag-Siah-1 or control empty vector were transfected 
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using Fugene6 (Roche) 24 hours after the transfection with siRNA. Cells were treated, 
unless otherwise
 
indicated, with 20 mM LiCl.
 
Nuclear and cytosolic extracts were 
prepared and 5 µg of extract was loaded on SDS-PAGE and followed by Western blot 
analysis using an
 
enhanced chemiluminescence reagent (Thermo Scientific). siRNAs 
were synthesized by Dharmacon Research and sequences are used as previously 
described [6].  All antibodies used in the Western blot are commercial available: β-
catenin (BD), TBL1 (Abcam), TBLR1 (Bethyl Laboratories), and α-Tubulin (Sata Cruz). 
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CHAPTER III 
 
TAMING THE BEAST: THE STRUCTURAL BASIS FOR THE FUNCTION OF TBL1 
 
Introduction 
The mechanism controlling the switch between gene activation and repression is 
critically important for understanding transcriptional regulation. Recent models for 
regulated gene expression in higher eukaryotes involve highly controlled, dynamic 
exchange between co-activators and co-repressors that are recruited to DNA bound 
transcription factors. TBL1 and TBLR1 are nuclear exchange factors initially identified 
as part of the nuclear receptor co-repressor (N-CoR) and silencing mediator for the 
retinoid and thyroid hormone receptors (SMRT) complexes [9, 60]. TBL1 and TBLR1 
have very high sequence identity, and are expressed from two different chromosome 
locations, TBL1 from chromosome X and TBLR1 from chromosome 3 [4]. Upon ligand 
activation of nuclear hormone receptors, TBL1 and TBLR1 mediate the release of the 
NCoR/SMRT co-repressor complex, and its poly-ubiquitination and subsequent 
proteasomal degradation. The discharge of the co-repressor complexes occurs in parallel 
with the recruitment of co-activators to the DNA promoter site. Interestingly, TBL1 
and/or TBLR1 were found present at the promoter site of hormone receptors in both the 
activated and the repressed state of the genes.   
In a similar manner, TBL1 and TBLR1 are also found to facilitate the exchange of 
co-activators with co-repressors from the Tcf/Lef transcription factors at Wnt promoter 
sites [6]. β-Catenin is a transcriptional co-activator in the Wnt signaling pathway that 
65 
 
mediates the expression of target genes such as c-Myc, cyclin D1 and matrix 
metalloproteinases (MMPs). Previous studies, as explained in more detail in chapter II, 
have demonstrated that in the absence of a Wnt ligand, the promoters of Wnt-targeted 
genes is occupied by the co-repressors TLE and HDAC1 that inhibit the firing of Wnt 
target genes [6]. The release of Wnt signals prevents the proteasomal degradation of β-
catenin, leading to the accumulation and TBL1-mediated recruitment of β-catenin to the 
promoter site of Wnt inducible genes. The localization of TBL1- β-catenin complex at the 
promoter displaces the co-repressors and induces the expression of the Wnt genes. ChIP 
analysis of Wnt target promoters identified TBL1 at the repressed Wnt promoter with 
TCF4, TLE and HDAC1, as well as in a complex with co-activators, β-catenin and TCF4, 
similar to the regulatory mechanism of nuclear hormone receptors [6]. These results 
demonstrate the function of TBL1 proteins as nuclear exchange factors that function in 
transcriptional control of gene expression. TBL1 and TBLR1 also play a unique role, not 
only participants in different multi-protein complexes, but also as facilitators of protein-
protein interactions. Despite the wealth of functional data, the molecular mechanism of 
TBL1-orchestrated recruitment of co-activators and co-repressors is not yet understood. 
Obtaining information about the structural architecture and the domain organization of 
TBL1 will provide valuable insights how it can facilitate the recruitment and formation of 
protein assemblies.  
TBL1 is a multi-domain protein that based on sequence homology is predicted to 
have an N-terminal LisH domain followed by FBox, coiled coil (CC) and WD40 domains 
(Fig. 3.1C). The LisH region of TBL1 is a known dimerization motif identified in more 
than 100 eukaryotic proteins [112]. The importance of the small LisH domain was 
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demonstrated in a mutational analysis of the residues conserved in TBL1-LisH [51]. 
Mutants with perturbed dimer subunit interface are not able to translocate to the nucleus 
and have a significant decrease in protein stability and half-life in the cell. 
 LisH domains are often found in concert with WD40 repeat domains, as is the 
case for TBL1. WD40 domains are  well recognized protein-binding modules in signaling 
proteins with a characteristic β-propeller structure. The ability of TBL1 to facilitate many 
protein interactions and to play a major role as a nuclear exchange factor is expected to 
be largely facilitated by the WD40 domain and the potentiality of TBL1 to oligomerize. 
Previous cell based experiments have shown that TBL1 forms homo- and TBL1/TBLR1 
hetero-oligomers, but what remains unknown is the exact oligomeric state of the 
complexes [51, 113].  
In order to gain insight into the function of TBL1, we have determined the 
oligomeric state of TBL1 and generated a structural model by combining small angle x-
ray scattering (SAXS) with homology modeling, and biochemical experiments including 
analytical ultracentrifugation (AUC) and size-exclusion chromatography - multi-angle 
light scattering (SEC-MALS) approaches. 
 
Results 
Production and oligomerization state of full-length TBL1  
In order to pursue biochemical and structural studies of TBL1, a method for the 
recombinant expression and purification of the full length protein was established. FL-
TBL1 constructs with N-terminal His6-, His6-SUMO- and GST- tags were expressed in 
different E.coli strains at 18, 22, 25 and 37
o
C. These expression and solubility tests 
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revealed that TBL1 was expressed predominantly in inclusion bodies, except for His6-
TBL1 and His6-SUMO-TBL1 grown at 18
o
C in Rosetta(DE3) cells. These conditions 
yielded soluble protein. Since the His6-TBL1 protein has a smaller N-terminal tag it was 
selected for all further experiments.  
To test the purity and homogeneity of the protein, we used negative stain electron 
microscopy (EM). The electron micrographs showed that these samples are highly 
contaminated, presumably with the E.coli chaperone GroEL. Further mass spectrometry 
analysis of the purified His6-TBL1 confirmed that the sample was contaminated with a 60 
kDa E. coli chaperone. The similarity of the molecular masses of His6-TBL1 and the 
E.coli chaperone (58.8 and 60 kDa, respectively) made the differentiation between the 
two proteins very challenging by SDS-PAGE or native gels. Moreover, TBL1 bound 
tightly to the chaperone and efforts to separate the two proteins were not successful. 
Thus, two new expression systems for TBL1 were developed, one involving baculovirus 
Sf9 insect cells and the other Human Embryonic Kidney (HEK) 293-6E cells (Invitrogen) 
with stably expressing Ebstein-Barr virus nuclear antigen 1 (EBNA) [90]. His6-TBL1 was 
successfully expressed in 293-6E cells in collaboration with Vito Quaranta’s laboratory 
and then produced by the protein expression core at Vanderbilt University.  
High yield of purified FL-TBL1 was produced following Co
2+
-affinity, anion 
exchange and size exclusion chromatography (SEC) (Fig. A3.1). Notably, the elution 
profile of TBL1 from SEC suggested that it was an oligomeric protein. In order to 
determine the oligomeric state of purified His6-tagged TBL1, SEC-MALS detection was 
undertaken (Fig. 3.1A, B). Analysis of the SEC-MALS profile indicated that the 
molecular mass of TBL1 is 245.7 kDa (1% error), which corresponds well to a tetramer. 
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These results are consistent with previous research demonstrating that Sif2p, the S. 
cerevisiae homologue of TBL1, also forms a tetramer [114].  
 
TBL1 oligomerizes through the LisH domain  
Disorder predictions indicate that TBL1 has two structured regions, the N-
terminal LisH-FBox (1-121) and the C-terminal WD40 domain (170-527), connected by 
a 50 residue linker (Fig. 3.1C). The LisH-FBox region covers residues 2-86, leaving 
residues 87-121 structurally uncharacterized. According to COILS prediction algorithms, 
 
Figure 3.1. Biochemical analysis of FL-TBL1, domain representation and constructs. A) 
Coomassie stained SDS-PAGE of FL-TBL1. B) Elution profile of TBL1 from Superose 6 
SEC-MALS in 25 mM sodium phosphate pH at 7.5, 200 mM NaCl, 5% Glycerol and 5 
mM βME. C) Schematic representation of TBL1 domains and list of deletion constructs.  
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residues (90-121) should form a coiled coil [115]. In order to further characterize the 
oligomerization state of TBL1 and determine the domains contributing to 
oligomerization, sedimentation velocity AUC experiments were performed using three 
TBL1 constructs: (LisH-FBox, 1-90), (LisH-FBox-CC, 1-124), (LisH-FBox-CC-linker, 
1-179) (Fig. 3.1C). A coomassie-stained gel of the pure recombinant proteins is shown in 
Fig. 3.2A. Analysis of the AUC velocity data for the largest construct, TBL1 (1-179, 21 
kDa) shows that it has a sedimentation value (s) of 3.30 +/- 0.004 (S). This corresponds 
to a molecular mass of 73 kDa and suggests the formation of a tetramer (Fig. 3.2B, C). 
Truncation of the 50 residue linker results in a highly stable construct TBL1(1-124) with 
a mass of 15 kDa, which sediments with an s value of 3.16 +/- 0.006, consistent with the 
formation of a 61 kDa tetramer. Thus, the linker does not have a significant contribution 
to tetramerization. Next, to test if the LisH-FBox domains are sufficient for the formation 
of a tetramer, sedimentation velocity experiment using TBL1(1-90) were performed. 
Analysis of the data shows that TBL1 (1-90, 12 kDa) has sedimentation value (s) of 3.19 
+/- 0.005, which is calculated to be 49 kDa and corresponds to a tetramer as well (Fig. 
3.2). Based on these results we can conclude that the LisH domain is the primary 
mediator of tetramerization and that the linker and putative CC are not required.  
The LisH is a known oligomerization domain that has been shown to induce 
protein dimerization in the Lis1 and FOP proteins, and tetramerization in Sif2p [114, 
116-117]. However, in order to confirm that the LisH is sufficient for the tetramerization 
of TBL1, a deletion mutant of TBL1 that lacks the LisH domain, but includes the FBox-
CC-linker (residues 31-179) was characterized. This mutant was not very stable and more  
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Figure 3.2. Analysis of sedimentation velocity data for TBL1 deletion mutants. (A) 
Purified His6-TBL1 constructs (1-90), (1-124) and (1-179) resolved on a coomassie-
stained SDS-PAGE gel. (B) Sedimentation coefficient distribution for each of the 
TBL1 constructs, the calculated sedimentation value [c(s)] is plotted as a function of 
the sedimentation coefficient (s). (C) Summary of the results from the sedimentation 
velocity analysis.  
71 
 
prone to aggregation than constructs that contain the LisH domain. Thus, the LisH also 
plays an important structural role in stabilizing the N-terminal region of TBL1. 
Considering the instability of the construct, we selected SEC-MALS instead of AUC to 
characterize the oligomerization state of this construct. A comparison of the elution 
profiles of TBL1(31-179) with TBL1(1-124) and TBL1(1-170) is presented in a 
chromatogram in Figure 3.3. The analysis of the MALS data showed that TBL1(31-179) 
had molecular mass of 17.4 kDa (error of 0.6%), which correspond well to the monomer 
mass of 17.6 kDa (Fig. 3.3). Together, these data clearly show that the predicted coiled 
coil region does not induce oligomerization on its own. We conclude that the LisH 
domain drives the formation of a stable TBL1 tetramer. 
 
Figure 3.3. SEC-MALS analysis of TBL1 truncation constructs. Overlay of 
chromatograms for TBL1(1-124), (31-179) and (1-170).  Purified proteins were 
resolved on a Superose  6 column,  by injecting 50 µl of TBL1(1-170) and (31-179) at 
5 mg/ml  and TBL1(1-124) at  6 mg/ml.  The molar mass was calculated to 54.1 kDa 
(0.2% error) for TBL1(1-124), 17.4 kDa (0.6% error) for TBL1(31-179) and 73.6 kDa 
(0.1% error) for TBL1(1-170). 
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Modeling of TBL1 domains  
LisH: The LisH (Lis1 homologous) is a known oligomerization domain found in 
more than 100 eukaryotic proteins with a variety of functions [112].  A model of the 
TBL1 LisH domain (LisH, 2-36) was generated by homology modeling using the 
program Modeller [118]. The 1.75 Å resolution x-ray structure of the Lis1-LisH dimer 
with sequence identity of 22 % was used as the template for the model of the TBL1-LisH 
 
Figure 3.4. Homology modeling of TBL1 domains. (A) Summary table of the details in 
generating the models of TBL1 domains. (B) Structures of the models arranged according 
to the table in A. Top: Homology model of the LisH dimer calculated by Modeller. The 
two protomers are colored in light and dark green; (next down) de novo fold of the 
putative FBox domain generated by Rosetta in purple; (next down) homology model of 
the α-helix from the putative coiled coil in brown; (bottom) homology model of WD40 
repeat domain in blue. C) Structure based sequence alignment of TBL1-LisH to Lis1-
LisH template generated by Modeller. Conserved residues within the dimer interface are 
marked in green. 
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domain (Fig. 3.4). Structure-based sequence alignment was generated and used as a basis 
to build the model (Fig. 3.4B, C). The LisH subunit formed a helical hairpin, which 
assembles into an anti-parallel LisH homodimer. Despite the limited overall sequence 
identity between TBL1-LisH and the Lis1-LisH template, the key anchor residues Val12, 
Tyr15, Leu16, Phe21 and Phe28 of the mostly hydrophobic interface between the 
subunits are well conserved (Fig. 3.4C). Furthermore, Glu31, which is crucial for the 
stabilization of the helices across the dimer interface, is highly conserved within all LisH 
domains including the TBL1-LisH domain [117].   
FBox: Immediately C-terminal to the LisH domain is the predicted FBox-like 
motif. FBoxes are domains of approximately 40 residues that bind Skp1, the adaptor 
protein in SCF E3 ubiquitin ligases [21, 103]. However, biochemical and functional data 
in our laboratory indicates that the FBox of TBL1 has unusually low (mM range) affinity 
for Skp1 and functional data from our laboratory suggests that TBL1 does not function as 
a classical FBox-substrate recruiting protein (chapter II) [119]. Despite these 
observations, we initially proceeded to generate a homology model of the TBL1 FBox-
like domain with Modeller. A template with multiple structure alignment of FBox 
domains from Skp2, Fbs1, Cdc4, β-TrCP, Fbw7 was created and used for the structure-
based sequence alignment of TBL1-FBox (Fig. A3.2A). The sequence identity between 
TBL1 FBox and the other FBox domains is extremely low, between 2-12%, which 
suggests care in interpreting the results of a homology model.  
Given the uncertainty of the FBox homology model, we utilized an orthogonal 
approach to generate additional structural models, i.e. de novo fold generated from 
sequence using Rosetta [120]. Based on the size (only 40 residues) and predicted α-
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helical nature, the FBox is well within the range for reliable structure prediction by 
Rosetta. The Rosetta calculation generated a three helix bundle that highly resembles the 
fold of the FBox domain (Fig. 3.4A, B, Fig. A3.2). 
Coiled coil: Between the LisH-FBox region (residues 2-86), residues 87-169 form 
a bridge/linker to the WD40 repeat domain (170-527). According to secondary structure 
prediction algorithms residues 90-121 will occupy α-helical conformation and based on 
COILS prediction algorithms, it should form a coiled coil [115]. Notably, 14 out of the 34 
amino acids in that region are alanines, 10 of which are consecutive in the sequence 
(Ala110 - Ala119), which strongly predicts to helical secondary structure. To build a 
model of this region, we selected a template, using the BioInfoBank MetaServer that has 
poly-Ala content and forms a coiled coil [121]. The 1.5 Å resolution x-ray structure of 
the antifreeze protein from winter flounder was used as a template with sequence identity 
of 35%, for the model of TBL1(90-120) (Fig. 3.4). The homology model of TBL1(90-
120) generated in this way, is an extended α-helix (Fig. 3.4B).  
The results from the oligomerization studies and the model of the TBL1 (90-120) 
raise the question whether residues 90-120 form a coiled coil or is simply a region with 
an α-helical character. The propensity of isolated TBL1(90-120) to fold as a coiled coil 
was tested by circular dichroism (CD). The ratio of molar ellipticity at 222 nm and 208 
nm ([222/208]) is used as a relative measure for the coiled coil nature of a protein, where 
a ratio ≥ 1 is indicative of coiled coil and a ratio of ≤ 1, of isolated helices. The predicted 
CC(90-120) was not produced alone, since the constructs that lack the LisH domain 
TBL1(31-179) and TBL1(31-103) are very unstable and prone to aggregation. 
Consequently, the molar ellipticity for that region was calculated by subtracting the CD 
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spectrum of TBL1(1-90) from that of TBL1(1-124) (Fig. A3.3). The helical content 
calculated for the two constructs using K2D2 is >80 % and the ratio of [222/208] is 0.68. 
This observation suggests TBL1(90-120) does not form a coiled coil, but exists as an 
isolated α-helix. We note that based on the biochemical data presented above, the 
predicted CC region of TBL1 is not sufficient to induce protein oligomerization, at least 
in the absence of the LisH domain (Fig. 3.3).  
WD40: TBL1(179-527) is predicted to fold into commonly known interaction 
domain, a WD40 repeat domain.  More than 20 WD40 repeat domain structures have 
already been determined, including the WD40 repeat domain of Sif2p, the homologue of 
TBL1 from S. cerevisiae [114]. The homology model of TBL1 WD40 was calculated 
using the structure based sequence alignment of Sif2p-WD40 template, which has 25% 
sequence identity with TBL1 (Fig. 3.4).  
WD40 repeats have a β-propeller fold, generally with 6 to 7 blades, with a few 
exceptions of proteins such as Sif2p and Cdc4, which have 8 blades [114, 122]. Each of 
the blades is a structural motif of four anti-parallel beta-strands formed from ~40 amino 
acids that end in a Trp-Asp sequence. Based on the well conserved sequence similarity 
and length between TBL1 and Sif2p WD40 domains, it is highly likely that TBL1 also 
has an unusual 8-bladed β-propeller fold. There are four loop regions in the Sif2p WD40 
structure: 191-196, 213-219, 303-317 and 477-490 [114]. In order to obtain the complete 
model of the TBL1-WD40 domain, the loops were built separately using Modeller. The 
final WD40 repeat domain model is shown in Figure 3.4B. 
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Figure 3.5. Sequence analysis of TBL1-LisH domain. A) Sequence comparison of TBL1-
LisH and Lis1-LisH domains. Conserved residues within the dimer interface of the two 
LisH sequences are underlined. Residues highlighted in green and yellow are identical or 
similar, non-conserved residues are in red. B) Sequence alignment of TBL1-LisH 
orthologues. Resides in green are at the conserved dimer interface and in red non-
conserved residues with the Lis1-LisH domain. C) The structure of the TBL1-LisH 
model and the surface representation below. The color scheme is consistent with the one 
in (A).  
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Design of LisH mutants that perturb TBL1 tetramerization  
The ability of TBL1-LisH and its yeast homologue, Sif2p, to form stable 
tetramers is a novel feature compared to the well characterized LisH-containing proteins 
Lis1 and FOP. This raises interesting questions as to the functional basis of 
tetramerization and which residues within this highly conserved LisH domain mediate 
formation of the tetramer. Answers to these questions are highly relevant to generating 
the structural model of TBL1 as a tetramer. As a result, we decided to map the interface 
between the LisH dimers of TBL1 by using site-directed mutagenesis and use this 
information to refine the structural model of the tetramer. 
The design of a mutant that can perturb the tetramerization of TBL1 was directed 
at the interface between the common LisH domain dimers. Our efforts were guided by 
the structural information of Lis1-LisH dimer and through sequence analysis. The 
conserved residues between these two LisH domains lie within the interface of the dimer, 
as described in detail above (Fig 3.4C). The sequence variability between the exposed 
residues of the LisH dimer from Lis1 and TBL1 is shown in a surface representation in 
Figure 3.5, with highly conserved residues in green and yellow, and non-conserved 
residues at the surface in red. As expected, the area with the highest conservation is at the 
dimer subunit interface and at the cavity formed on the bottom of the dimer (Fig. 3.5B 
and D). This generally hydrophobic cavity serves as the packing area of the domain 
positioned C-terminal to the LisH as illustrated in the Lis1 and FOP structures [116-117]. 
The non-conserved solvent-exposed residues of TBL1-LisH dimer include Phe10, Leu11, 
Tyr13, Arg14, Ser22, Phe26, Ile30 and His33, which represents a relatively hydrophobic 
platform and a possible oligomerization site (Fig. 3.5A). Sequence analysis of the LisH 
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motif of TBL1 homologues shows that Leu11, Tyr13, Arg14, Gln17, Glu18 are identical 
from human to yeast and Phe10 and Phe26 are also highly conserved as large 
hydrophobic residues (Fig. 3.5B). His33 is highly homologous throughout all species, 
whereas Ser22 and Ile30 are not conserved in yeast (Fig.3.5B). Based on the sequence 
conservation within the TBL1-LisH homologues and the difference of these residues 
compared to the LisH of Lis1 and FOP dimers, we hypothesize that Phe10, Leu11, Tyr13, 
Arg14, Ser22, Phe26, Ile30 and His33 are at the tetramer interface of the TBL1-LisH 
dimers. 
 
Design of TBL1 dimer mutant 
In order to test the functional role of TBL1 tetramerization, we set out to produce 
a TBL1 mutant that only forms dimers based on the hypothesis generated from sequence 
analysis. We began with the full seven point mutant of TBL1(1-124), where each residue 
was swapped to the corresponding amino acid from the Lis1-LisH domain: Phe10Arg, 
Arg14Asp, Gln17Arg, Glu18Ser, Ser22Glu, Phe26Ser and His33Glu (Fig. 3.6A). The 
TBL1(1-124) construct with these 7 mutations (TBL1(1-124)-7M) was expressed and 
purified using the protocol developed for the wild type (wt) construct. The 
oligomerization state of this protein was initially determined by size exclusion 
chromatography. Comparison of the elution profiles from a Superose 6 column of the wt 
TBL1 with the mutant shows a peak shift of 1.1 ml (Fig. 3.6B). This result is consistent 
with a change in molecular mass from approximately 60 kDa tetramer to a 30 kDa dimer.  
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Having been successful with the design of TBL1(1-124)-7M, we next sought to 
determine the minimum number of residues required for tetramerization. Seven 
constructs with different numbers and combinations of point mutations were designed, 
expressed and purified then analyzed by CD in order to confirm that α-helical secondary 
structure is retained (data not shown). The oligomeric state of these mutants was 
investigated by SEC-MALS (Fig. 3.7A, B). Mutants 4, 5, 6, 7 and 8 have a significant 
peak shift to a molecular mass of a dimer, compared to the wt protein and mutants 2 and 
3, which form tetramers (Fig. 3.7A and B). Sequence comparison of the point mutants 
indicate that the change of Phe26 to Ser is present in all constructs that form a dimer  
 
Figure 3.6. Design of TBL1-LisH mutants. A) Homology model of TBL1-LisH dimer. 
The marked residues are not conserved with the Lis1-LisH domain and used for 
designing TBL1-LisH mutants. B) Comparison of elution profiles for TBL1(1-124) wt 
at 80 µM and TBL1(1-124) mutant 5: Phe10Arg, Arg14Asp, Gln17Arg, Glu18Ser, 
Ser22Glu, Phe26Ser, His33Glu at 120 µM. The proteins were run on a Superose 6 
column in buffer containing 25 mM Tris-Cl, pH 7.5, 200 mM NaCl, 5 mM βME. 
Coomassie stained SDS-PAGE of the eluted proteins.  
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Figure 3.7. Biochemical analysis of TBL1-LisH(1-124) mutants. A) Summary table of 
mutants. B) SEC-MALS elution profile of mutants. The proteins were run on a 
Superdex 200 analytical column in a buffer containing 25 mM Tris-Cl, pH 7.5, 200 
mM NaCl, 5 mM βME. B) Analysis of TBL1(1-124) mutant 4. Left: Sedimentation 
coefficient distribution, the calculated sedimentation value [c(s)] is plotted as a 
function of the sedimentation coefficient (s). Right: CD spectra of TBL1(1-124) wt 
and mutant 4.   
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(mutants 4-8), which suggests that Phe26 alone is the critical hydrophobic residue for the 
formation of a stable tetramer. However, even though the elution profile of mutant 8 
(Phe26Ser, His33Glu) is indicative of a dimer it has a polydispersity greater than 50%, 
which suggests that mutation of Phe26 is not sufficient to shift the equilibrium from a 
tetramer to a stable dimer. The construct also containing: Arg14Asp, Gln17Arg and 
Glu18Ser produces a dimer with much lower polydispersity. However, this mutant was 
very prone to aggregation during concentration of the protein. Addition of mutations 
Phe10Arg and Ser22Glu proved sufficient to prevent aggregation. Thus, the mutant 
containing Phe10Arg, Arg14Asp, Gln17Arg, Glu18Ser, Ser22Glu and Phe26Ser forms a 
stable dimer with molar mass of 28 kDa and polydispersity of less than 10%. The CD 
spectrum of this mutant shows the expected α-helical secondary structure (Fig. 3.7C). 
Furthermore, AUC sedimentation velocity experiments with this mutant produced a 
sedimentation value (s) of 2.6, which corresponds to a molar mass of 35 kDa, confirming 
the formation of a dimer.  
 
Structural analysis of TBL1 by SAXS  
Since we have directly established that TBL1 is a tetramer, the next step was to 
build a tetramer model. There are numerous potential tetramer architectures, even if only 
the LisH domain is considered. Thus, in order to directly characterize the molecular 
architecture of TBL1 tetramer in solution, we used SAXS. SAXS is a powerful low 
resolution technique that can provide information about the size, shape and 
conformational dynamics of a molecule or molecular assemblies. Our approach in 
studying TBL1 by SAXS was to collect data on a series of constructs including: TBL1 
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(LisH-FBox, 1-90), TBL1 (LisH-FBox-CC, 1-124)) and the full length protein, FL-
TBL1(1-527) (Fig. 3.1C).  
SAXS data was first acquired for TBL1(1-90) and TBL1(1-124) (Fig.3.8A). Since 
the scattering data represents the electron pair distribution of all molecules in solution, 
the quality of the sample is absolutely critical for proper data analysis. The 
monodispersity of TBL1(1-90) and TBL1(1-124) was confirmed by SEC-MALS and 
only the samples with correct molecular weight, ~50 μl from the top of the elution peak, 
were used  for SAXS data acquisition (Fig. A3.4). SEC-MALS and Guinier analyses 
were used to verify that there was no sample aggregation (Fig. A3.4). Analysis of the 
Kratky plot (Fig. 3.8B) for the two constructs indicates that the proteins are well folded 
 
Figure 3.8. SAXS analysis of TBL1(1-90), (1-124) and FL proteins. A) Scattring 
curves, B) Kratky plot, C) Table with SAXS data statistics and D) P(r) functions. 
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with small degree of flexibility. Based on the symmetry of the curves, there appear to be 
no major changes in the LisH-FBox construct upon the addition of the putative CC region 
(Fig. 3.8B). The radius of gyration for the two TBL1 constructs, based directly on the 
Guinier analysis, differ by only 2.8 Å: Rg = 36.1 +/- 0.08 for (1-90); Rg = 38.9 +/- 0.1 for 
(1-124) (Fig. 3.8C). This suggests that the entire TBL1(1-124) construct forms an 
integrated structural unit. 
Distance distribution functions (P(r)) generated by GNOM for TBL1(1-90) and 
TBL1(1-124) have a characteristic bell shape, which is indicative of the presence of a 
near spherical globular domain (Fig. 3.8D). The presence of a slightly elongated shoulder 
at longer distances suggests an overall extended conformation of the protein. The 
maximum dimensions (Dmax) of TBL1(1-90) and TBL1(1-124) in the P(r) functions are 
128 Å and 137 Å, respectively (Fig. 3.8C). In comparing to proteins with similar 
molecular weight, the Dmax value of ~130 Å suggested an overall extended 
conformation of the protein [123]. These results were further supported by velocity AUC 
experiments, which provided frictional ratios for TBL1(1-90) of 1.5 and TBL1(1-124) of 
1.8 (Fig. 3.2C). Together, the SAXS and AUC results imply that the LisH-FBox(-CC) 
region of TBL1 has an elongated structural organization rather than a tightly packed 
spherical globular architecture. 
SAXS data were collected for FL-TBL1 (Fig. 3.8A). Analysis by SEC-MALS 
showed the sample was a tetramer with a monodispersity of less than 2% (Fig. A3.4). The 
radius of gyration calculated by Guinier analysis was 78.4 +/- 1.96, almost two times 
larger than that of the N-terminal domain constructs. This was consistent with an 
extended conformation of the protein (Fig. 3.8). Kratky analysis of FL-TBL1 suggested a 
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relatively rigid overall organization compared to the two truncated constructs, evident 
from the parabolic shape of the curve and closer return to baseline at higher scattering 
angle (Fig. 3.8B). Therefore the addition of the WD40 domain appears to stabilize the 
overall structure. 
Comparison of the pair distribution function of FL-TBL1 with TBL1(1-90) and 
TBL1(1-124) revealed two distinctive peaks at 25 Å and at 100 Å (Fig. 3.8D). The first 
peak correlates very well with the peak from the curves of TBL1(1-90) and TBL1(1-124), 
which reflects the scattering from the globular, nearly spherical LisH domain. The second 
distinctive peak in the curve of the FL protein corresponds to the large WD40 repeat 
domain, which contains 66 % of the total TBL1 sequence. The Rg value of 78.4 Å for the 
FL-TBL1 calculated from the P(r) function was consistent with the Rg value of 80.8 Å 
from the Guinier analysis, which supported the validity of the analysis (Fig. 3.8C). 
Comparison of the Dmax values for TBL1(1-90) and TBL1(1-124) of ~130 Å to the 
Dmax of 264 Å for the FL protein implies a spatial organization of the domains in which 
the WD40 is not folded onto the N-terminal region of TBL1, but extends away from the 
tetramerization core.  
 
Structural model of full-length TBL1 tetramer 
The biochemical and biophysical analysis presented above clearly demonstrates 
that TBL1 forms a stable tetramer through the LisH core with an extended organization 
of the domains. Formation of the LisH dimer was predicted with high confidence based 
on the homologous high resolution structures of Lis1-LisH and FOP-LisH, which formed 
stable dimers, but what remained unclear was whether the oligomeric TBL1 formed a 
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parallel dimer of dimers or an extended, anti-parallel dimer of dimers. The evidence from 
the SAXS data was an excellent tool for addressing this critical question. The estimated 
length based on the structural models for each of the TBL1 domains was ~25 Å for LisH, 
~25 Å for FBox and 50 Å for the CC region. Therefore the two TBL1 constructs (LisH-
FBox: 1-90) and (LisH-FBox-CC: 1-124) have expected Dmax of approximately 50 Å 
and 100 Å respectively, if the proteins form a parallel dimer of dimers. Comparison of 
these measurements to the experimental SAXS values of 128 Å and 137 Å for TBL1(1-
90) and TBL1(1-124), respectively, strongly supported a model in which TBL1 formed 
an anti-parallel dimer of dimers. Furthermore, the estimated maximum dimension for a 
fully parallel tetramer of TBL1 would correspond to the Dmax of a single subunit, i.e. ~ 
150 Å. In contrast, a tetramer formed from anti-parallel dimers would have a Dmax value 
substantially larger than 200 Å, consistent with the experimentally observed Dmax of  
264 Å. 
To obtain further insight into the structure of TBL1, ab initio molecular envelopes 
were generated for TBL1(1-90) and TBL1(1-124) using DAMMIN. The ten low 
resolution models obtained from the different runs were aligned, averaged and filtered 
based on occupancy with the program DAMAVER (Fig. 3.9A) [74]. The structural model 
for each of the truncation constructs has an elongated shape with a distinct dip or 
narrowing in the middle of the structure, which would correspond to the interface 
between the LisH dimer of dimers.  
Ab inito shape reconstruction was then undertaken for FL-TBL1 using DAMMIN 
and GASBOR. The low-resolution models from each of the programs were filtered with 
DAMAVER [74]. Similar results were obtained whether or not information about the 
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symmetry of the tetramer was enforced. The FL-TBL1 model has an overall S-shape that 
resembles a two-arm windmill, each arm representing one TBL1 dimer. The rotational 
axis through the center of the molecule runs through the interface of the LisH dimers 
(Fig. 3.9A). The width of the base is ~170 Å, which fits the molecular envelopes of 
TBL1(1-90) and TBL1(1-124). Thus the LisH-FBox-CC domains are positioned at the 
tetramerization core of the model as expected (Fig. 3.9B). The two large globular 
domains at the end of each arm have a spherical shape and approximate dimensions of 
50x65x70 Å, which corresponds well to the two WD40 domains per arm.  
Figure 3.9. SAXS ab initio models. A) Averaged ab initio models for TBL1(1-90) in 
cyan, TBL1(1-124) in purple and FL-TBL1 in blue. B) Overlay of the three TBL1 
models.   
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In order to further refine the spatial organization of each of the domains, we fitted 
the homology models for each domain into the molecular envelope. As noted above, the 
LisH domain provides the tetramerization core of the model and fits into the center of the 
molecular envelope. The structure of the LisH tetramer was manually fitted into the 
envelopes calculated for the truncated constructs and translated into the model for the FL-
TBL1. Two FBox domains per dimer were also manually fitted into the low resolution 
envelope, although the exact orientation or packing between the FBoxes or onto the LisH 
domain was unclear (Fig. 3.10). The two WD40 domain structures fit well into the 
 
Figure 3.10. Structural model of FL-TBL1. The homology models for the TBL1 
domains are manually fitted in the SAXS based ab initio envelope of FL-TBL1. 
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globular envelopes extended out from the core (Fig. 3.10). The exact placement of the 
putative CC (90-120) remained unclear. Comparison of the Dmax values for TBL1(1-90) 
and (1-124) showed a difference of only ~10 Å, which was further reflected in nearly 
complete overlapping of the models (Fig. 3.9). This suggested that in the absence of the 
WD40 domain, the predicted CC-like α-helical structure does not extend away from, but 
rather folds onto the LisH-FBox region. Between the CC and the WD40 repeat domains 
are 50 residue linkers, which according to disorder prediction algorithms are highly 
unstructured. However, the Kratky analysis of the FL protein implied there were no 
extraneous unstructured residues (Fig. 3.8B). Furthermore, limited proteolysis 
experiments of FL-TBL1 also implied that the tetramer is highly packed, since it did not 
provide flexible linkers easily accessible for digestion (Fig. A3.5). Therefore, it is likely 
that the CC and linker regions are structured and position the WD40 repeat domains in a 
specific orientation. Overall, we find highly extended structural organization of the 
tetramer, which provides a large surface area for the recruitment of binding partners and 
for the formation of multi-protein assemblies.  
 
Discussion 
TBL1 proteins are essential transcriptional regulators of the Wnt/β-catenin 
pathway and nuclear hormone receptors. The role of TBL1 and TBLR1 in recruitment 
and exchange of co-activators and co-repressors at DNA promoter sites has been 
demonstrated, but their mechanism of function remains unknown. To begin to address 
this challenge, we pursued structural and biochemical characterization of TBL1. Using 
sedimentation AUC and SEC-MALS analyses we demonstrated that TBL1 forms a stable 
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tetramer through the LisH oligomerization domain. Further insights into the structural 
architecture of full length TBL1 and the spatial organization of the domains were 
obtained by SAXS. TBL1 forms an anti-parallel dimer of dimers and an ab initio model, 
generated from SAXS data has an S-shape that resembles a two-arm windmill, each arm 
representing one TBL1 dimer (Fig. 3.9). A homology model of the LisH tetramerization 
core fits into the center of the molecular envelope and the substrate-binding WD40 repeat 
domains are at the end of each arm (Fig. 3.10).  
Our structural model of the TBL1 tetramer provides insights into its ability to 
form multi-protein complexes. The extended global architecture of an anti-parallel dimer 
of dimers presents a large surface area that can accommodate multiple binding partners. 
In order to test the functional role of TBL1 tetramerization in facilitating the formation of 
multi-protein assemblies, we have designed and produced a TBL1 mutant that forms only 
a dimer, thus setting the stage for functional analysis in cell-based experiments.  
 
Insights into the TBL1 model: comparison to LisH-containing proteins Lis1 and FOP 
To gain further insights into the functional mechanism of TBL1, we compared our 
model to the structures of Lis1 and FOP proteins, which also contain LisH and/or WD40 
repeat domain. The LisH motif was initially identified as a ubiquitous dimerization 
sequence, present in more than 100 eukaryotic proteins [112]. Interestingly, about 40% of 
these proteins are also found to contain a WD40 repeat domain, a major protein 
interaction unit. The Lis1 and FOP proteins provided the first insights into the structural 
organization of LisH-containing proteins, demonstrating that they exist as stable dimers 
[116-117, 124-125]. The domain composition of TBL1 is very similar to the 410-residue 
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Lis1 protein, with an N-terminal region containing LisH-CC domains and a C-terminal 
seven bladed WD40 repeat. The only identifiable region from the sequence analysis of 
the 399-residue FOP protein is the N-terminal LisH domain.  
The crystal structure of Lis1(1-86) first revealed the LisH dimerization fold. This 
structure confirmed an anti-parallel four-helix bundle that extends into an asymmetric CC 
with two parallel helices [116]. The asymmetry of the LisH-CC structure comes from a 
distinct kink in one of the CC helices, which according to NMR analysis provides a high 
degree of flexibility allowing the exchange between open and closed conformations of 
the two CC helices [124]. The Lis1-CC region is not sufficient to induce protein 
dimerization, but contributes to the stability of the N-terminal Lis1 fragment, similar to 
what we have observed for the predicted CC region of TBL1. The second LisH structure 
is from the FOP protein [117]. It revealed the same anti-parallel dimerization fold, and a 
conserved hydrophobic network of residues at the interface of the dimer core, which is 
also conserved in TBL1.   
Information about the domain organization of a full length oligomeric protein that has 
LisH and WD40 domains is available from the crystal structure of Lis1 in complex with 
platelet activating factor acetylhydrolase (PAF-AH) substrate [125]. The Lis1 homodimer 
binds the PAF-AH homodimer through the WD40 β-propeller domains. Even though the 
crystals contained full length Lis1, the N-terminal region of Lis1(1-90) was not observed 
in the electron density. Based on the distance between the two WD40 propellers that 
sandwiched the PAF-AH dimer, a large conformational change in the CC from a closed 
to an open state, must have occured in order to facilitate the binding of the substrate.  
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The ab initio model of TBL1 was calculated in the absence of a substrate. The overall 
S-shape of the tetramer indicates that the domains within a TBL1 dimer are not aligned 
orthogonally; instead, there is a kink in the structure of the FBox, CC or the linker region 
(Fig 3.9, 3.10). This structural organization is seen in the asymmetric LisH-CC fragment 
of Lis1 that is induced by a significant kink in one of the CC helices [116]. Thus, the 
domain organization of Lis1 in the absence of a substrate may resemble that of an 
asymmetric TBL1 dimer. The large conformational change in the Lis1 CC that 
accommodates the binding of a substrate may also be necessary in order for the TBL1 
WD40 repeat domains to recruit a substrate. Performing SAXS experiments with TBL1 
in complex with a substrate would provide a direct confirmation if there is a common 
substrate-mediated switch between open and closed conformations in these LisH-WD40-
containing proteins.  
 
TBL1 and TBLR1 function as scaffolding proteins 
TBL1 and its close homologue, TBLR1 are transcriptional regulators essential for the 
proper function of nuclear hormone receptors and Tcf/Lef families of transcription 
factors. While TBL1 and TBLR1 have been identified as “nuclear exchange factors”, 
they share many common features with scaffolding proteins: (i) interactions with 
different proteins within a specific pathway or process, (ii) recruitment of substrates to a 
designated cellular location, (iii) coordination of the function of positive and negative 
signaling factors, and (iv) facilitation of the formation of multi-protein complexes [126-
127]. TBL1 and TBLR1 tightly regulate the activation of many genes in the Wnt 
signaling pathway. In addition to interacting with the transcription factor TCF4, 
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TBL1/TBLR1 also bind and recruit co-activator β-catenin to the promoter site upon 
activation of Wnt signaling. In the absence of a Wnt ligand, TBL1/TBLR1 are associated 
with co-repressors TLE and HDAC1 at Wnt promoters and are required for the exchange 
of these repressors with the β-catenin activator [6]. Taken together, these observations 
suggest the involvement of TBL1/TBLR1 in negative and positive transcriptional control 
of Wnt signaling and that they function as scaffolding proteins.  
In a similar manner, TBL1 and TBLR1 play an essential role as scaffolding proteins 
in regulating the transcriptional outcome of nuclear hormone receptors. TBL1 and 
TBLR1 are involved in coordinating the negative and positive signaling factors of NHRs.  
In the absence of a ligand, TBL1/TBLR1 recruits transcriptional co-repressors, such as 
CtBP or the NCoR/SMRT complex, therefore inhibiting the activation of the nuclear 
receptors. Upon ligand stimulation, TBL1/TBLR1 facilitates the release and proteasomal 
degradation of co-repressors by directly binding and recruiting the ubiquitination 
machinery. Further investigation of the mechanism of TBL1 and TBLR1 as scaffolding 
proteins will provide critical insights into the mechanism of regulating the transcriptional 
activity of NHRs. 
 
Experimental methods 
Subcloning  
The subcloning of the expression plasmid for recombinant murine TBL1 has been 
previously described (chapter II and [119]). To obtain TBL1 truncation constructs (1-90), 
(1-124), (1-170) and (31-179), the DNA sequence was amplified from the full length 
cDNA of TBL1 and inserted into a pET28a vector (Novagen) with NdeI and EcoRI 
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restriction enzymes. The plasmid contains a thrombin-cleavable N-terminal His6-tag. 
Point mutants of TBL1(1-124) in pET28a vector were generated using a Quikchange 
(Stratagene) mutagenesis protocol. The correct sequence of all constructs was confirmed 
by DNA sequencing (Vanderbilt University DNA sequencing core).  
 
Purification of FL-TBL1 
The expression and purification protocol for recombinant FL-TBL1 has been 
previously described (chapter II and [119]). This protocol has been further optimized to 
produce high purity FL-TBL1 for analytical biochemical and structural studies. 250 mL 
of FL-TBL1 growth from HEK 293-6E cells was resuspended in 20 mL lysis buffer: 50 
mM Na2HPO4 at 7.5 pH, 500 mM NaCl, 10% Glycerol, 10 mM Imidazole, 5 mM β-
Mercapto Ethanol (βME), 1mM PMSF, 0.1% Tween-20, 0.2 mg/ml lysozyme and one 
Complete Mini EDTA-Free protease inhibitor cocktail tablet (Roche). The cells were 
incubated on ice for 20 min. and lysed by sonication at 4 
o
C. Soluble protein was isolated 
by centrifugation at 21,000 rpm for 25 min. at 4 
o
C. 
His tag purification (Co): His6-tagged TBL1 was purified by gravity flow at 4 
o
C 
using TALON® Co
2+
-affinity resin (Clontech). The equilibration and wash buffers 
included 50 mM Na2HPO4 at pH 7.5, 500 mM NaCl, 10% Glycerol, 5 mM βME and 10 
mM or 20 mM Imidazole for the two buffers, respectively. The supernatant from the cell 
lysis was loaded onto the pre-equilibrated 2.5 mL Co-resin and incubated for 30 min at 4 
o
C. After 10 CV wash with the wash buffer, FL-TBL1 was eluted in 25 mL wash buffer 
containing 300 mM Imidazole.  
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Anion exchange chromatography: The purity of the sample was verified on a 
NuPAGE gel (Invitrogen) stained with SimplyBlue SafeStain (Invitrogen). TBL1 was 
purified by anion exchange chromatography using Source-Q 10/10 column (Amersham 
Pharmacia Biotech). The pure fractions were pooled and dialyzed against the QA buffer 
containing 50 mM Na2HPO4 at pH 7.5, 50 mM NaCl, 10% Glycerol and 5 mM βME for 
~14 hrs at 4
 o
C. Protein was loaded onto the Source-Q column pre-equilibrated in a QA 
buffer and washed with 12 CV of QA buffer. A two step elution gradient was used to 
elute TBL1, 5 CV from 0 - 210 mM NaCl and 5 CV from 210 – 1000 mM NaCl.  
Size exclusion chromatography: The last step of TBL1 purification and initial 
characterization of the oligomeric state of the protein was done by size exclusion 
chromatography. After equilibration of the Superose 6 10/300 GL (GE Healthcare) with 2 
CV of running buffer (50 mM HEPES at pH 7.5, 200 mM NaCl, 5% Glycerol and 5 mM 
βME), 0.5 mL of TBL1 was loaded and run at 0.3 mL/min.    
  
Protein Expression and purification of TBL1 constructs 
TBL1 truncation constructs (1-90), (1-124), (1-170), (31-179) and TBL1(1-124) 
mutants were expressed in the Escherichia Coli Rosetta (DE3) strain. Starter cultures 
were grown overnight in Luria-Broth (LB) at 37 
o
C and used to inoculated 1 L LB 
cultures for protein expression. The cells were grown until they reached A600 of 0.8-1.0 
and were then induced with 0.1 mM isopropyl thiogalactoside (IPTG) for 4 hrs at 37 
o
C. 
The cells were harvested by centrifugation at 8,000 x g for 15 min and the pellet stored at 
-80 
o
C. 
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His tag purification (Ni): The His6-tagged proteins were affinity purified on a 
Ni
2+
-NTA column (Qiagen) using 25 mM Tris-Cl at pH 7.5, 300 mM NaCl, 10 mM 
Imidazole, 5 mM βME as NiA buffer and 300 mM Imidazole in the NiB buffer. A 20 mL 
hand poured Ni
2+
-column was equilibrated with NiA resin before loading the cell lysate. 
After washing with 10 CV of NiA containing 20 mM Imidazole, the protein was eluted in 
a 5 CV linear gradient to 100 % NiB buffer.  
Anion exchange chromatography: TBL1 constructs were further purified by anion 
exchange chromatography as for FL-TBL1, except the QA buffer contained 30 mM Tris-
Cl at pH 7.5, 50 mM NaCl and 5 mM βME. The protein was eluted in a 10 CV linear 
gradient of NaCl from 50 – 500 mM NaCl.  
Size exclusion chromatography: The final step in the purification of the TBL1 
constructs was size exclusion chromatography using Superdex 75 10/300 (Amersham 
Pharmacia) column. Between 0.1 – 1 mL of protein sample was loaded per run in a buffer 
containing 30 mM Tris-Cl at pH 7.5, 200 mM NaCl and 5 mM βME.  
All of the TBL1(1-124) mutants were purified following the protocol for FL-
TBL1. 
 
Circular dichroism (CD) 
TBL1 constructs were buffer exchanged into 10 mM Na2HPO4 at pH 7.5, 2.7 mM 
KCl, 1.8 mM KH2PO4  and 100 mM NaCl. The far-UV CD sectrum was collected using 
Jasco J-180 spectrophotometer (Easton, MD). The spectra were scanned form 195 – 260 
nm at 22 
o
C using protein samples with final concentration between 1.5 – 10 µM. 
Percentage of secondary structure was estimated with the K2D2 web server [128]. 
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Analytical ultracentrifugation (AUC) 
Sedimentation velocity experiments were performed with a Beckman Optima XL-
A analytical ultracentrifuge (Beckman-Coulter, Fullerton, CA) with absorbance optics. 
TBL1 samples were dialyzed into 25 mM Tris-Cl at pH 7.5 and 200 mM NaCl and tested 
at concentrations from 50 – 400 µM. Double sector cells with charcoal-filled Epon 
centerpiece (pathlength 1.2 cm) and quartz windows were filled with 395 µl protein 
sample and 400 µl of matching buffer. Using a 4-hole An60Ti rotor the samples were 
centrifuged at 40,000 rpm at 22
 o
C. The velocity experiments were analyzed with the 
program Sedfit (version 9.3) [64]. Approximately 300 scans collected 60 s apart were 
used for each analysis for a final confidence level of p = 0.95 and a resolution of n = 200.   
 
Limited proteolysis 
FL-TBL1 was subjected to limited proteolysis with chymotrypsin in buffer 
containing 25 mM Tris-Cl at pH 7.5, 200 mM NaCl, 5 mM βME and 10 mM CaCl2. The 
digestion was carried out using 1:400 ratio of protease:protein at room temperature. 
Aliquots were taken at different time points and the reactions stopped with the addition of 
trypsin inhibitor. The samples were resolved on an SDS-PAGE and stained with 
SimplyBlue SafeStain (Invitrogen). 
 
Size-exclusion chromatography - multi-angle light scattering (SEC-MALS) 
SEC-MALS analyses were performed for mass determination and evaluation of 
sample polydispersity. MALS experiment were performed using a DAWN HELEOS 8+ 
light scattering detector connected to a refractive index (RI) concentration detector and 
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quasielastic light scattering (QELS) detector (Wyatt Technology). Superose 6 10/300 GL 
(GE Healthcare) and Superdex 200 (GE Healthcare) columns were used for the analysis 
of TBL1 constructs and full length protein, respectively. SEC running buffer for TBL1(1-
90) and (1-124) contained 30 mM Tris-Cl at pH 7.5, 200 mM NaCl, 5% Glycerol and 5 
mM βME and for FL-TBL1, 50 mM Na2HPO at pH 7.5, 200 mM NaCl and 1% Glycerol. 
The system was equilibrated with 50 μl (Superose 6) and 25 μl (Superdex200) of BSA at 
a concentration of 10 mg/ml in SEC running buffer. Analysis of TBL1(1-90), (1-124) and 
full length protein were run on samples with concentrations ranging from 1 – 10 mg/ml in 
the specified SEC running buffer.  
 
SAXS data collection and processing 
SAXS data of TBL1 constructs were collected at the Advanced Light Source at 
the SYBILS beamline (12.3.1) at Lawrence Berkeley National Laboratory (Berkeley, 
CA). Scattering measurements were collected on 20 μl protein sample in serial dilution 
between 10 - 0.5 mg/ml and on the corresponding matching buffers using a 96-well plate 
(Nunc) covered with protective film. A Hamilton syringe robot was used for an 
automated loading of the protein samples into the sample cuvette, as previously described 
[75]. Sequential exposures (1, 10 and 1s) for all TBL1 samples were taken at room 
temperature. The first and last exposures for each sample were used to evaluate for 
radiation-damage. The scattering vector, q is defined as q = 4π sin (/2)/λ, where /2 is 
the scattering angle and λ is the wavelength in Å. The data were collected over the q 
range of 0.007-0.31 Å
-1
 with the sample-to-detector distance maintained at 1.486 m and 
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with a wavelength of 1.3 Å (12,000 eV). Analysis of the data was performed with the 
ATSAS software package [129].  
 The raw scattering data, I(q), were scaled and the buffer subtracted. The 
experimental data were first evaluated for aggregation based on the Guinier plots using 
the program PRIMUS. A linear correlation in the plot of log(I(q)) vs. q
2
, confirms the 
quality of the sample. The scattering data from different concentrations were scaled and 
merged using the program PRIMUS [130]. The radii of gyration (Rg) was derived based 
by the Guinier approximation with limits of qRg<1.3 for TBL1(1-90), TBL1(1-124) and 
qRg<1.5 for FL-TBL1. The pair distribution function P(r) was calculated using the 
program GNOM. This program also directly extracts an estimate of the maximum 
dimension (Dmax) of the molecule [71]. 
Kratky plots were generated for each of the TBL1 constructs to evaluate the 
foldedness of proteins using PRIMUS. The samples of well-folded particles with no 
interparticle interference were selected for ab initio modeling. For each SAXS dataset, 
multiple independent DAMMIN and/or DAMMIF runs were performed, averaged and 
filtered with the program DAMAVER [74]. The molecular graphics were generated using 
PyMol (DeLano Scientific, Paulo Alto, CA). 
 
Homology modeling 
The modeling of TBL1 LisH, FBox, CC and WD40 domains were performed 
using the Modeller 9v8 software [118]. The templates were chosen based on the highest 
sequence identity of available 3D structures; the specific templates for the domains are 
listed in Fig. 3.4. The structure based sequence alignment was obtained using the 
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standard “align2d.py” script for LisH, CC and WD40 domains and the model was built 
using the “model- single.py” script. A template with five aligned FBox x-ray structures 
was created with “salign.py” (Fig. A3.2). The structure based alignment of the FBox 
from TBL1 with FBox 3D structures was obtained with “align2d_mult.py” and the FBox 
models built with “model_mult.py”. 
The models were evaluated using the “evaluate_model.py” script and the final 
structure selected based on the molpdb score and the lowest discrete optimized protein 
energy (DOPE) potential. 
 
Rosetta 
De-novo structure prediction of the Fbox domain of TBL1 was performed using 
Rosetta software version 3.1 [131]. The 51-residue sequence 
[INGTLVPPAALISILQKGLQYVEAEISINEDGTVFDGRPIESLSLIDAVM] was 
initially folded at low resolution using Monte Carlo fragment insertion with the -abinitio 
and -fastrelax keywords and the residue-level centroid scoring function to generate 1000 
candidate structures. The best-scoring 25% of structures were subjected to clustering with 
a per-cluster RMSD radius of 4Å using Rosetta's clustering function, to identify the 
putative most native-like fold [132]. The lowest energy member of the largest cluster was 
refined using Rosetta's relax mode, which performs cycles of local perturbation and 
gradient-based minimization to produce a high-resolution full-atom model. The final 
model was additionally refined with AMBER version 10 to remove any remaining 
clashes, using 20 cycles of steepest-descent and 480 cycles of conjugate-gradient 
minimization in the ff99SB force field [133-134]. 
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CHAPTER IV 
 
DISCUSSION AND FUTURE DIRECTIONS 
 
Summary of this work 
TBL1 in β-catenin activation of Wnt target genes 
The studies presented in this work provide information about the structural 
architecture of TBL1 isoforms and insights into their function as transcriptional 
regulators. The origin of this work was an investigation of the biochemical and structural 
basis for phosphorylation–independent poly-ubiquitination of β-catenin by the SCFTBL1 
complex. By establishing an in vitro ubiquitination system, we were able to characterize 
the proposed SCF
TBL1
 complex, testing separately the function of each component of the 
complex including Siah-1, SIP, Skp1 and TBL1 (chapter II).  
We discovered that Siah-1 alone can function as the E3 ubiquitin for non-
phosphorylated β-catenin and that it assembles Lys11 ubiquitin chains on the substrate. 
Substrates with Lys11 linkages are known targets for proteasomal degradation, which is 
in agreement with cell based studies performed by us and other groups demonstrating that 
overexpression of Siah-1 results in a decrease of cellular β-catenin levels [13, 49, 119]. 
Our results also lead directly to questioning the formation and physiological significance 
of SCF
TBL1
. In addition, we mapped the ubiquitination sites on β-catenin to Lys666 and 
Lys671, which indicates that Siah-1 targets different lysine residues compared to the 
Wnt-regulated SCF
β-TrCP
 complex that assembles ubiquitin chains on Lys19 and Lys49 of 
phosphorylated β-catenin substrate [48]. These data provided further evidence for the 
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existence of multiple pathways that are involved in precisely regulating the turnover and 
therefore the activity of such a critical transcriptional co-activator as β-catenin. Most 
significantly, our studies brought to light new ideas about the roles of TBL1 in regulating 
the activity of β-catenin. Evidence from the in vitro ubiquitination data suggests that 
TBL1 protects β-catenin from recruitment and ubiquitination by Siah-1 (chapter II). 
These experiments are supported by our cell based studies demonstrating that TBL1 also 
inhibits Siah-1 targeted poly-ubiquitination and degradation of β-catenin during Wnt 
signaling. This work established that both Siah-1 and TBL1 bind the armadillo repeat 
domain of β-catenin, suggesting a competitive mode of interaction. The ensemble of data 
was used to generate a model for the regulation of β-catenin by Siah-1 and TBL1 (Figure 
2.7). Hence, what started out as an investigation of a complex SCF-like E3 ubiquitin 
ligase, turned into a study of the role of TBL1 as a scaffold for the exchange of nuclear 
transcription factors.  
 
TBL1 and TBLR1 function as scaffolding proteins  
We demonstrated that TBL1 forms a stable tetramer through the LisH 
oligomerization core (chapter III). Starting from multiple sequence alignment of LisH 
homologues, the binding interface between pairs of LisH dimers was mapped by site 
directed mutagenesis. A stable TBL1 LisH dimer mutant was produced and confirmed 
with biochemical and biophysical methods. Direct information about the global 
architecture of the TBL1 tetramer was obtained from SAXS experiments that were used 
to generate an ab initio model for the protein. We found that TBL1 has an extended S-
shape conformation with two-fold symmetry through the LisH tetramer (Fig. 3.9). The 
102 
 
spatial organization of the TBL1 domains was deduced based on direct comparison of the 
ab initio models for TBL1(1-90), TBL1(1-124) and the full length protein. The homology 
models for each of the TBL1 domains were generated and fitted into the low resolution 
envelope, providing critical information about the placement of the N-terminal LisH 
tetramerization core and the C-terminal WD40 domain (Fig. 3.10). The structure of the 
FBox-CC-linker region has a significantly higher degree of uncertainty due to the lack of 
high resolution structural information or a high confidence homology model. 
The model for the global architecture of TBL1 has provided a number of critical 
insights and set the stage for new experiments. The extended conformation of the protein 
indicates that the position of the WD40 domains in a TBL1 dimer is distant from the 
LisH core, an architecture that can facilitate the formation/stabilization of large protein 
complexes. Furthermore, the formation of the TBL1 dimer of dimers through the LisH 
core suggests a possible mechanism of action for TBL1 in which the LisH dimers serve 
as a hinge during the exchange of co-activator and co-repressor complexes at the 
promoter site of NHRs. Thus, the model has provided fundamental new insights into 
TBL1 function and a foundation for the design of biochemical experiments to test the role 
of TBL1 family members as nuclear exchange factors.  
 
Implication of the results 
The mechanism of transcriptional activation mediated by β-catenin and NHRs is 
of high interest because defects in their regulatory pathways are found to be a major 
cause for many cancers, cardiovascular diseases, and neurodegenerative disorders [37-38, 
61-62]. In fact, components from these pathways have become an attractive target for 
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anti-cancer drugs [38, 44]. The challenge of interrupting or stimulating specific protein 
complexes that affect the transcriptional activities of β-catenin and NHRs without 
affecting other functions is being heavily pursued. TBL1 and TBLR1 have been only 
recently identified as transcriptional exchange factors of co-activators and co-repressors 
of β-catenin and NHRs, and their mechanism of function remains unknown. Determining 
that TBL1 forms a stable tetramer with an extended S-shape provides new insight into the 
basis for formation of regulatory complexes of β-catenin and NHRs. These findings may 
have a significant impact in advancing our understanding of the assembly/disassembly of 
the transcription machinery and of the mechanism of exchange between transcriptional 
co-activators and co-repressors. 
 
The function of TBL1 isoforms 
There are three known TBL1 homologues in humans, the X-linked TBL1 protein, 
chromosome 3-linked TBLR1 and Y-linked TBL1Y, in addition to a number of other 
isoforms identified for TBL1. X-linked TBL1 and TBLR1 have been implicated in 
mediating the function of the transcriptional co-activator β-catenin and of NHRs [6-7]. 
TBL1Y is the least studied family member and its role has not been determined yet. In 
general, many of the X-linked genes that are duplicated in the Y-chromosome perform 
the same functional role in the cell. However, despite the high sequence identity between 
X- and Y-chromosome linked TBL1 proteins, TBL1Y cannot compensate for the 
function of TBL1, which is highly ubiquitous and can bypass the X-chromosome 
inactivation [4].  
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TBL1 family members share >80 % sequence identity, but have two distinctive 
features that may be contributing to their functional differences and substrate specificity: 
unique phosphorylation sites and distinct lengths of the linker between the CC region and 
the WD40 repeat domain. Figure 4.1 represents a sequence alignment of TBL1 family 
members from human and mouse. The overall sequence identity between LisH, FBox-
like, CC and WD40 domains is very high. Furthermore, sequence identity between 
human and mouse X-linked TBL1 orthologues is 95% and TBLR1 orthologues is 99% 
(Fig. 4.1).  
One of the clear differences between X-linked TBL1 and TBLR1 are the unique 
Ser and Thr sites in the WD40 domain and the linker (Fig. 4.1). Studies using mouse 
TBL1 and TBLR1 demonstrated that the release of co-repressors from each of the 
proteins is dependent on the phosphorylation of Ser123 and Ser199 for mouse TBLR1 
versus Ser175, Thr334 and Ser420 for mouse TBL1 [10]. The phosphorylation sites are 
also different for each of the TBL1 or TBLR1 homologues in human and mouse. Thus, 
phosphorylation appears to be a primary factor in determining the functional specificity 
of TBL1 family proteins.  
The second distinctive feature within the TBL1 family members is the linker 
between the CC region and the WD40 repeat domain. TBL1 has a 45 amino acids long 
linker that is 12 residues longer than TBLR1 and notably six of the extra residues are 
either Ser or Thr. This suggests a link between the linker length/identity and 
phosphorylation.  It is possible that recruitment of substrates to TBL1 proteins is 
dependent on the pattern of phosphorylation within the linker, which is coupled as well to 
the length of the linker.  
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Figure 4.1. Sequence alignment of TBL1 homologues generated in CLUSTALW [2]. The 
proteins in the alignment are: Human TBL1, linked to chromosome X_isoform 1 (hTBL1X_i1) – 
ID: O60907; hTBL1X_i2 - O60907-2; hTBL1, chromosome Y (hTBL1Y) - Q9BQ87; hTBL1X 
related 1, chromosome 3-linked (hTBL1XR1) - Q9BZK7. Mouse TBL1 X –linked (mTBL1X) - 
Q9QXE7; mTBL1-related 1, chromosome 3 linked, (mTBL1XR1) - Q8BHJ5.  
Residues marked with “*” are identical, “:” strongly similar, “.” weakly similar. 
The alignment highlighted in gray represents identical regions, in yellow - Ser and Thr residues.  
The color lines under the sequence represent TBL1 domains, green - LisH, purple – FBox-like,  
CC - beige, linker – red, WD40 – blue.   
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Our structural model of substrate-free TBL1 places two of the WD40 domains in 
relatively close spatial proximity to each other (Fig. 3.10). Therefore, in order for a 
substrate to bind at the surface of the WD40 repeats it is likely that the two WD40 repeat 
domains are separated. This may arise from lateral displacement of the domains or a 
conformational change in the FBox-CC-linker region. It is possible that the 
phosphorylation of specific residues in the loop can trigger such structural changes to 
increase access to the WD40 domains. Another level of substrate specificity could derive 
from the length, where the shorter linker of TBLR1 homologues could provide a 
geometric restraint on the ability to recruit large binding partners. 
Interestingly, SAXS and limited proteolysis experiments suggest that mouse 
TBL1 (mTBL1), which has a 50 residue linker, has a fairly overall rigid architecture 
(chapter III, Fig. 3.8B, A3.5). This suggests that the length of the linker itself is not 
sufficient to induce high degrees of interdomain flexibility. Additional experiments 
would be necessary to determine if phosphorylation of mTBL1 would have an effect on 
the dynamics of the protein and its ability to recruit binding partners. In order to test this, 
phosphorylated TBL1 and TBLR1 proteins can be purified from in vitro kinase reactions 
and the flexibility of the proteins measured by SAXS and limited proteolysis. A similar 
approach can be used to test the role of the linker length by producing deletion mutants 
for SAXS and proteolysis experiments. Comparison between the wild type and TBL1 
mutants will enable more specific statements to be made about the extent and importance 
of TBL1 structural dynamics.  
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Tight links between TBL1 and Siah-1, but not in an SCF complex 
 The role of TBL1 in mediating the activity of β-catenin by recruiting it to the 
promoter site of Wnt target genes has been established [6]. Our research also supports the 
role of TBL1 as a co-activator of β-catenin by protecting it from Siah-1-targeted poly-
ubiquitination and proteasomal degradation during Wnt signaling (chapter II). Previous 
experiments also demonstrated that TBL1 forms a complex not only with the Wnt co-
activators, β-catenin and TCF4, but with co-repressors such as CtBP1/2 [6, 10]. The 
obvious question is whether TBL1 is actively involved in exchanging β-catenin co-
activators for co-repressors at the promoter site of Tcf/Lef transcription factors. The role 
for TBL1 family members in the exchange between co-activator/co-repressor complexes 
of NHRs has already been established and it is highly probable that a similar mechanism 
is in place for the regulation of Wnt target genes [60]. The experimental evidence from 
Perissi and colleagues also suggests that the exchange is facilitated by Siah-1-targeted 
poly-ubiquitination and degradation by the proteasome. Furthermore, the experimental 
evidence suggests that both Siah-1 and the 19S proteasome could be recruited to the co-
activator and co-repressor complexes by TBL1 family members [10, 60].   
The recently developed evidence for the correlation between Siah-1 and TBL1 
provides some insights into the initial conclusions that TBL1 is involved in a Siah-1-
mediated SCF
TBL1
 complex. The authors hypothesized that Siah-1 mediates the formation 
of an SCF complex that targets β-catenin for ubiquitination because (i) Siah-1 interacts 
with APC, a known binding partner of β-catenin that mediates its degradation through 
another SCF ligase, the SCF
βTrCP
 complex, and (ii) transient transfection of Siah-1 leads 
to a drastic decrease of β-catenin levels in cells [13, 49, 135]. The role of TBL1 in this 
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Siah-1-mediated complex was pursued based on experimental evidence for the function 
of Ebi, the Drosophila homologue of TBL1, in recruiting Ttk88 for poly-ubiquitination 
by SINA (the Drosophila homologue of Siah-1) [12].  
Matsuzawa and colleagues tested the hypothesis that Siah-1-mediates an SCF-like 
complex containing Siah-1, SIP, Skp1 and TBL1 that targets β-catenin for poly-
ubiquitination. The evidence presented for the protein-protein interactions between E2-
Siah-1, Siah-1-SIP, SIP-Skp1 and Skp1-TBL1 were based on yeast two-hybrid and three-
hybrid assays further “confirmed” by transient transfections followed by co-
immunoprecipitations [13]. The lack of strong experimental evidence demonstrating a 
direct physical interaction of the proteins in the putative SCF
TBL1
 complex and the 
possibility that a direct interaction between Siah-1 and TBL1 could have contributed to 
the misleading conclusions by Matsuzawa and colleagues. Furthermore, our biochemical 
and in vitro data demonstrating that the TBL1-FBox domain does not bind the adaptor 
protein, Skp1, thus precluding the formation of a stable SCF complex (chapter II), 
suggests that the proposed SCF
TBL1
 complex is not physiologically relevant.  
So, what is the relationship between Siah-1 and TBL1? Notably, there is a 
growing number of binding partners that interact with both Siah-1 and TBL1 (Table 4.1). 
Interestingly, TBL1 is necessary for the Siah-1-mediated poly-ubiquitination of certain 
substrates such as CtBP1/2 and NCoR [10-11]. In addition, the degradation of these 
substrates depends on TBL1-mediated recruitment of the 19S proteasome to DNA 
promoter sites. Our experiments have shown that TBL1 does not function as an FBox-
WD40-substrate recruiting receptor for SCF complexes and confirms the function of 
Siah-1 as a simple E3 ligase (chapter II). Thus, it is highly possible that TBL1 serves as a 
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chaperone in recruiting substrates to Siah-1 for poly-ubiquitination, and subsequently to 
the proteasome for degradation.  
A physical interaction between TBL1 and Siah-1 has been identified in a large 
yeast two-hybrid proteomics screen and reproduced by GST-pull down [136]. Of course 
these experiments need further confirmation, but a direct physical interaction between 
Siah-1 and TBL1 would be additional evidence for the chaperone function of TBL1 as a 
scaffolding protein in recruiting both Siah-1 and substrates to close proximity. Once a 
substrate is poly-ubiquitinated, the chaperone-like function of TBL1 could be extended to 
binding and recruiting the proteasome for efficient substrate degradation.  
If TBL1 proteins function as chaperones of Wnt regulators, could TBL1 be also 
involved in the Siah-1-mediated poly-ubiquitination of β-catenin? Despite our finding 
that TBL1 inhibits Siah-1 targeted degradation of β-catenin during Wnt signaling, our 
 
Table 4.1. Summary of TBL1 and Siah-1 binding partners.  
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data does not provide evidence if additional signaling events favor the release of β-
catenin for poly-ubiquitination. Since the phosphorylation of TBL1 leads to the release 
and degradation of CtBP, which is a co-repressor for NHRs and β-catenin, post-
translational modifications of TBL1 could be a direct signal for stimulating the chaperone 
role of TBL1 proteins. In order to test this, phosphorylated TBL1 can be produced in an 
in vitro kinase assay and the effect of the post-translational modification investigated by 
performing an in vitro ubiquitination reaction of β-catenin with Siah-1 as the E3 ligase. If 
phosphorylated TBL1 releases β-catenin, and serves as a chaperone for the Siah-1 E3 
ligase, we would expect to observe an efficient in vitro poly-ubiquitination of β-catenin.  
 
The role of TBL1 oligomerization  
One of the critical features characterized in our biochemical and structural 
analyses is the ability of TBL1 proteins to form a stable dimer of dimers through the N-
terminal LisH domain. Even though we have been able to map the residues at the binding 
interface of the dimers, determining the exact binding affinity has been challenging. The 
methods that were used to determine the oligomerization state of TBL1 include SEC-
MALS, interference AUC and SAXS, with the lowest detectable concentrations of TBL1 
estimated to be at least 2 μM. The data from these experiments have captured TBL1 only 
at a tetrameric state, which is a strong indication that the affinity of the two dimers is at 
least in the nM range (chapter III).  
However, this data does not provide direct information about the oligomeric state 
of TBL1 in cells. TBL1 is a predominantly nuclear protein and its concentration in the 
cytoplasm is very low, which could lead to dissociation into a TBL1 dimer. The high 
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abundance of TBL1 and TBLR1 in the nucleus and especially at DNA promoter sites 
would increase the local concentration of the proteins, leading to the formation of homo- 
and hetero-tetramers. Even more interesting is the effect of binding partners on the 
oligomerization state of TBL1 family members. One possibility is that TBL1 binds 
substrates as a dimer in the cytoplasm and after nuclear translocation it associates into 
homo- and hetero-tetramers to stabilize the formation of large protein assemblies. It is 
also possible that TBL1 forms tetramers only at promoter sites of target genes of Wnt or 
NHRs. However, if the affinity of the TBL1 dimer of dimers is very high, it is also likely 
that TBL1 and TBLR1 recruit specific substrates to the promoter sites as homo-tetramers. 
Then, the assembly of the multi-protein co-activator or co-repressor complexes may 
require the formation of a TBL1/TBLR1 hetero-tetramer through subunit exchange, with 
each of the homo-dimers bringing a specific substrate to the complex. 
The formation of tetramers could be an essential function for the scaffolding 
mechanism of TBL1 proteins. For instance, β-catenin binds both TBL1 and TBLR1, 
whereas transcription factor TCF4, which directly interacts with β-catenin to induce 
transcriptional activation of Wnt target genes interacts with TBL1, but not TBLR1. 
However, it has not been demonstrated if the formation of a TBL1 hetero-tetramer is 
required for the simultaneous recruitment of TCF4 and β-catenin at the Wnt promoters. 
The mutants that we designed to perturb TBL1 tetramerization and form only a stable 
dimer would be an excellent tool for testing the effect of TBL1 oligomerization in cells. 
Considering the complexity of the system and the fact that cell-based experiments do not 
provide a reliable answer for the direct interaction of protein complexes, an in vitro 
reconstitution of the system would be necessary. Determining the stoichiometry and the 
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structural organization of Wnt regulatory complexes such as co-activators TBL1-β-
catenin-TCF4 and co-repressors TBL1-CtBP, TLE-HDACi would provide important new 
insights into the mechanism of TBL1 as an essential transcriptional regulator of Wnt 
signaling.   
Functional implications of TBL1 in regulating NHRs 
It has been well established that transcriptional regulation of NHRs at a target 
promoter site involves a tightly controlled switch between the recruitment of co-
activators (Co-A) and co-repressors (Co-R) (Fig. 1.7) [10, 60]. Using cell-based 
experiments, a number of groups have demonstrated the critical scaffolding role of TBL1 
and TBLR1 in mediating the direct exchange of these regulatory complexes from the 
NHRs by recruiting them for poly-ubiquitination and proteasomal degradation. Our 
structural and biochemical studies revealed for the first time the extended global 
architecture of the mTBL1 tetramer (chapter III), setting the stage for pursuing further 
functional and structural studies.  
 
Proposed model for the mechanism of TBL1 proteins as nuclear exchange factors 
  Even though the high affinity of the LisH dimers suggests the formation of a 
TBL1 tetramer in vitro and in cells, we cannot exclude the possibility that low protein 
concentration and the interaction with certain binding partners could alter the 
oligomerization state. We propose the following model for the recruitment and exchange 
of substrates by TBL1 and TBLR1 (Fig. 4.2). The low concentration of TBL1 and 
TBLR1 in the cytoplasm allows the formation of homo-dimers that bind and recruit 
substrates to the nucleus or NHR promoter sites (Fig 4.2, (1) and (4)). The increased local  
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Figure 4.2. Proposed model for the mechanism of TBL1 homologues as scaffolding 
proteins of NHRs. 1) In the absence of a ligand, TBL1 and TBLR1 homo-dimers bind 
and recruit different co-repressor components (Co-R*) to the hormone receptor (HR). 
TBL1 proteins facilitate the assembly of the entire co-repressor (Co-R) complex at the 
HR promoter by forming a TBL1/TBLR1 hetero-tetramer through the N-terminal 
LisH domain. The Co-R complex inhibits HR-targeted gene transcription. 2) Ligand 
stimulation of the HRs leads to TBL1-mediated poly-ubiquitination and recruitment of 
the proteasome to the Co-R complex. 3) Release and degradation of the TBL1/TBLR1 
Co-R complex, which leads to low transcriptional activation of HR genes. 4) Co-
activator components (Co-A*) are recruited by TBL1/TBLR1 homo-dimers to ligand 
activated HRs. Assembly of the entire co-activator (Co-A) complex through the LisH 
hinge of the TBL1/TBLR1 hetero-tetramer leads to the complete activation of HR-
targeted gene transcriptional. 5) Transcriptional repression of HRs is restored by 
TBL1-mediated poly-ubiquitination of the Co-A complex and recruitment of the 
proteasome. 6) The exchange of the Co-A complex for Co-R complex is allowed by 
the release and proteasomal degradation of the HR activator components.  
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concentration in the nucleus and at specific promoter sites would lead to the assembly of 
stable tetramers. Since the LisH is the core oligomerization domain, which is completely 
conserved between TBL1 family members, it is conceivable that TBL1 and TBLR1 
hetero-oligomers can form (Fig. 4.2, (2) and (5)). In order to facilitate the exchange 
between the Co-A and Co-R complexes, TBL1 proteins have been suggested to directly 
recruit E3 ubiquitin ligases such as Siah-1, for poly-ubiquitination of the complex. 
Subsequently, TBLR1 binds the 19S proteasome and mediates the release and 
proteasomal degradation of the NHR bound complex (Fig. 4.2, (3) and (6)). Whether 
TBL1 and TBLR1 are also degraded during the exchange of the Co-A/Co-R complexes 
remains unclear. The two proteins are found at both the activated and repressed promoter 
sites, but the evidence was obtained from chromatin immunoprecipitation (ChIP) 
experiments and does not provide information about the dynamics of the exchange and 
the fluctuation of TBL1/TBLR1 levels [60].  
 
Future directions 
TBL1 and TBLR1 are essential factors for the transcriptional activation of NHRs, 
and absolutely necessary components in both the co-repressor and co-activator complexes 
[60]. Further analyses of the function of TBL1 proteins have shown that they recruit the 
19S proteasome and mediate the ubiquitination and degradation of NHR and their co-
factors at the promoter site [7, 60]. However, despite a wealth of functional data 
demonstrating the critical role that TBL1 and TBLR1 proteins play in mediating the 
transcription of NHRs, the mechanism that dictates the role of these scaffolding proteins 
in the precise exchange of the co-activator and co-repressor factors remains a critical gap 
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in knowledge. The research presented in my thesis work demonstrates that TBL1 forms a 
stable tetramer that has an extended S-shape conformation that may facilitate the 
recruitment of large protein assemblies. These data provided fundamental new insights 
into the mechanism of TBL1 and TBLR1 in mediating the activity of NHRs. 
Furthermore, this work can have a significant impact in the design of new experiments to 
precisely investigate this novel mechanism of TBL1 as an exchange factor of NHRs. 
In order to test the model  for the function of TBL1 (Fig. 4.2), an experimental 
approach going beyond characterizing single, isolated proteins is required, one which will 
undertake the challenge of studying the entire system both in vitro and in cells. Due to the 
number and complexity of TBL1-protein interactions, the goal of the experimental design 
is to establish a basic, but comprehensive in vitro system that will serve as a guide to test 
the mechanism of TBL1 proteins in cells. The discoveries will be confirmed and the 
mechanism tested in a cell-based luciferase reporter assay that will serve as a functional 
readout for the transcriptional activation of NHRs, such as the estrogen receptor (ER). 
The flowchart in Figure 4.3 is a representation of the proposed future goals that would 
provide an in-depth understanding of the mechanistic role of TBL1 proteins, and this 
strategy is summarized in the following sections. 
I. In vitro reconstitution of the system 
In order to compare the role of TBL1 family members in the exchange of co-
activator and co-repressor factors from NHRs, the complexes need to be recombinantly 
expressed and purified (Fig. 4.3, I). These complexes include the ER co-activators: 
steroid receptor co-activator 1 (SRC1), p300 and CREB binding protein (CBP); and co-
repressors: NCoR, SMRT, HDAC3 and GPS2 [11, 137]. Many of these factors have been  
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Figure 4.3. Experimental plan for studying the mechanism of TBL1-facilitated exchange 
between NHR co-activator and co-repressor complexes. Arrows show the information feedback 
of the different experimental approaches. 
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successfully produced before, but in order to make the functional full length proteins, 
different heterologous and mammalian expression systems should be pursued. Since the 
regulatory system of NHRs is mostly conserved in yeast and the function of Sif2p, the 
yeast homologue of TBL1, also resembles the one in humans, if necessary the 
experiments could be performed in a more basic and less complex system with the co-
activator and co-repressor complexes from S. cerevisiae.  
II. Biochemical and biophysical characterization 
Our finding that TBL1 forms a stable dimer of dimers has lead to some very 
interesting questions regarding the formation of activator and repressor complexes and 
the mechanism that mediates their exchange from the NHRs. These questions include: 
what is the oligomerization state of TBL1 and TBLR1 alone and in the complexes with 
binding partners: are they in a homo- or hetero- oligomeric state? What is the 
stoichiometry of the various complexes and how does this relate to the oligomeric state of 
TBL1? And finally, as proposed in our model, are individual substrates recruited by 
TBL1 dimers that associate with the complex through the formation of a TBL1 tetramer?  
In order to address these questions, a combination of biochemical and biophysical 
techniques such as AUC, SEC-MALS, SAXS will need to be used to determine the molar 
mass of the targeted complexes and the stoichiometry of the components (Fig. 4.3, II). 
NMR experiments will need to be performed to map the binding interface of specific 
protein interactions. ITC and AUC equilibrium experiments would be informative for 
measuring the affinity of dynamic protein interactions. TBL1 mutants that were designed 
to perturb the dimer of dimer interface (chapter III) would be very instrumental in 
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addressing many of the mechanistic questions and confirming the oligomerization state of 
TBL1 proteins in the co-activator and co-repressor complexes.  
III. Structural analysis 
The most powerful approach for characterizing the structural architecture of large 
protein assemblies is to collect complementary data with multiple techniques such as 
crystallography, NMR, EM and SAXS (Fig.4.3, III). X-ray crystallography is the main 
technique to determine the structures of large, conformationally-stable proteins and 
protein sub-complexes, and can provide valuable high resolution data. Considering the 
internal flexibility and the size of the co-activator and co-repressor complexes (>800 
kDa), crystallization may not be possible and negative stain EM might provide a more 
general approach for elucidating the structural architecture of these macromolecules. The 
precise positioning of the proteins within the complex can be obtained by specifically 
labeling each of the components individually. Knowledge of the spacial organization of 
the proteins within the complex is crucial for reconstructing the entire assembly and for 
modeling the high resolution structures of the sub-complexes. Additional structural 
information about the sub-complexes in solution can be obtained by SAXS. Since the 
data collected by SAXS experiments is a summation of all molecules in solution, it 
provides low resolution structural information.  However, when combined with high 
resolution NMR and crystallography data, it can bring critical knowledge about the 
shape, conformational dynamics and the spatial organization of different components in 
the complex. 
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IV. In vitro assays 
The function of many regulatory factors, including TBL1 and TBLR1 is regulated 
by post-translational modifications (PTMs) with two of the most common ones being 
protein phosphorylation and ubiquitination. Furthermore, the exchange between the co-
repressor and co-activator complexes has been found to depend on the TBL1-mediated 
poly-ubiquitination and proteasomal degradation of the components in each complex [10, 
60]. In order to test the effect of these PTMs, (i) an in vitro kinase assay for TBL1 family 
members and (ii) an in vitro ubiquitination assay for co-repressor/co-activator 
components should be established (Fig. 4.3, IV).  
In vitro kinase assays are well established and can be performed using GSK3 and 
Casein kinase 1 (CK1), which have been demonstrated to target specific phosphorylation 
sites of TBL1 and TBLR1 [10]. The precise PTMs will be verified by mass spectrometry 
analysis. Post-translationally modified substrates will be purified and the effect of these 
modifications on the formation and dynamics of the co-activator and co-repressor 
complexes can be further characterized using structural and biochemical approaches (Fig. 
4.3, II and III).  
Previous studies have shown that some of the TBL1-binding proteins from the co-
activator and co-repressor complexes are poly-ubiquitinated by Siah-1, leading to their 
proteasomal degradation [60]. The in vitro ubiquitination assay we have established with 
Siah-1 (chapter II) can be used to test activity on TBL1-binding partners as well as the 
effect of TBL1 phosphorylation. The protocol for the in vitro ubiquitination assay can be 
optimized for different E3 ubiquitin ligases. It would also be interesting to determine the 
rate of poly-ubiquitination and proteasomal degradation of the entire complex by adding 
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purified 26S proteasome to the ubiquitination reaction. The ubiquitin linkage assembled 
on the substrates could be analyzed by mass spectrometry. 
V. Establishing luciferase reporter assay 
A luciferase assay for the gene activation of NHRs can be used to specifically test 
TBL1 mutants that provide insight into the proposed nuclear exchange mechanism. A 
luciferase reporter assay would provide the functional readout in testing the mechanistic 
role of TBL1 determined by the structural and biochemical analyses (Fig. 4.3, V). The 
luciferase assay is a well established method used to quantitate gene expression. The 
luciferase DNA vector can be designed to include an estrogen response element (ERE) 
[137]. The transcriptional activation of the ER leads to the expression of luciferase 
protein and a bioluminescent reaction when exposed to a luciferin substrate. The light 
emitted by the reaction is directly proportional to the amount of the expressed enzyme, 
and therefore the binding and activation of the ER.  
To begin the analysis, the functional relevance of perturbing TBL1 
tetramerization on the activation of NHR would need to be tested. Next, the effect of 
mutating specific TBL1-protein interaction sites and PTM sites should be measured with 
the assay, after knocking down the wt proteins and introducing the mutants. Finally, the 
functional data can be used to develop a better experimental design for future structural 
and biochemical research. 
VI. Summary 
The proposed future directions in this chapter are highly specialized in 
characterizing the mechanism of TBL1 proteins in mediating the transcriptional activity 
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of NHRs. The experimental approach includes reconstitution of a co-activator and co-
repressor complex of NHR for an in-depth biochemical and structural characterization 
(Fig. 4.3). Details from the structural information will be used to formulate hypotheses 
that can be further examined in cells and in in vitro assays. The main priority in the 
experimental approach of investigating the mechanistic role of TBL1 is to pursue high 
resolution structure determination of TBL1 in a complex with co-repressors such as 
NCoR and SMRT. The hypotheses generated from the structural data can be tested by 
designing TBL1 mutants that can be used in the biochemical and functional experiments 
presented above. The cross-reference approach can provide critical insights into the 
complex system of the scaffolding TBL1 proteins. 
 
Concluding remarks 
The necessity of proper transcriptional activation by NHRs and β-catenin is 
demonstrated by the observation that dysregulation of these processes participate in the 
initiation and progression of many diseases, including cancer. Though undeniably 
critical, our knowledge of the role TBL1 proteins play in regulating gene transcription 
through NHRs and β-catenin is quite limited. Since it is an essential regulator of these 
transcription factors, in-depth understanding of the functional mechanism of TBL1-
mediated protein assemblies is important. The extended structural architecture of 
tetrameric TBL1, discovered in my thesis work, can have important implications in 
understanding its mechanistic role as a scaffolding protein and nuclear exchange factor.  
Another critical part of my thesis work is providing new understanding of the 
interplay between Siah-1, as an E3 ubiquitin ligase and TBL1, a mediator of its function 
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and a possible chaperone. The evidence presented in chapter II demonstrates that Siah-1 
can directly target β-catenin for poly-ubiquitination and proteasomal degradation and 
previously published data demonstrates that Siah-1 also targets specific co-regulators of 
NHRs [138]. Notably, many of the Siah-1 targets are also binding partners of TBL1 
(Table 4.1). My work provides evidence that Siah-1 and TBL1 do not work together in an 
SCF
TBL1 
complex, but possibly through a novel mechanism, where TBL1 functions only 
as a chaperone that modulates the E3 ligase activity of Siah-1.   
Protein turnover is one of the major regulatory processes of protein function, 
therefore insights into the mechanism of Siah-1 and TBL1 in mediating the levels of β-
catenin and co-regulators of NHR could have a significant impact in finding new ways to 
regulate their function and transcriptional activation. Considering the complexity of the 
system, the answers will not emerge from a single approach, whether structural or 
functional. Moreover, an interdisciplinary approach that utilizes the data generated from a 
combination of biochemical, structural, cellular and clinical research will enable the 
translation of our knowledge into a deeper understanding of diseases and effective 
therapeutic design.  
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APPENDIX A 
 
Supplementary Figures 
 
 
 
Figure A2.1. CD spectrum of β-catenin-FL. 
 
  
124 
 
 
Figure A2.2. Full scale of the Coomassie stained SDS-PAGE gel from Figure .2.1B.(A)  
In vitro ubiquitination of β-catenin by Siah-1 with wt- and K(0)-ubiquitin(B). 
  
FL-β-catenin + + - + + + + + +
E1/UbcH5a - + + + + + + + +
Ubiquitin - - + + + + + + +
Siah-1  - + + + + + + + -
TBL1 - + + + + - + + +
Skp1   - + + + + + - + +
SIP      - + + + + + + - +
ATP - + + - + + + + +
Time (min) 60 60 60 60 60 60 60 60 60
Lane 1 2 3 4 5 6 7 8 9
98
188kDa
β-catenin
β-catenin-(ub)nE1
TBL1
SIP
Skp1
SIP-(ub)n
62
49
38
28
Siah-1
Supplementary Figure S2. 
A. B.
FL-β-cat [µM] 0.3 0.3 0.3 -
E1/UbcH5a + + + +
Ubiquitin wt K0 K0 K0
Siah-1    [µM] 0.5 0.5 0.5 0.5
ATP + + - +
Time (min) 60 60 60 60
Lane 1 2 3 4
β-catenin
Siah-1
E1
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Figure A2.3. In vitro ubiquitination of β-catenin by Siah-1 in the presence of (A) Skp1 
and (B) SIP. 
FLβ-cat [0.25µM] + + + + + + + - - -
E1/UbcH5a - + + + + + + + - -
ubiquitin - + + + + + + + - -
Siah-1     [0.2µM] - + + + + + + + - -
Skp1 [0.25-1.5µM] - - - + + + + + + +
ATP - - + + + + + + - -
Time (min) 60 60 60 60 60 60 60 60 60 60
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Supplementary Figure S3. 
FLβ-cat [0.25µM] + + + + + + + - - -
E1/UbcH5a - + + + + + + + - -
ubiquitin - + + + + + + + - -
Siah-1     [0.2µM] - + + + + + + + - -
SIP [0.25-1.5µM] - - - + + + + + + +
ATP - - + + + + + + - -
Time (min) 60 60 60 60 60 60 60 60 60 60
Lane # 2 3 4 5 6 7 8 9 10 11
SIP
SIP-(Ub)n
β-cat.
β-cat.(Ub)n
98
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49
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FL-β-catenin + + + + + + + + + + + + + + + +
E1/UbcH5a + + + + + + + + + + + + + + + +
ubiquitin + + + + + + + + + + + + + + + +
Siah-1    + + + + + + + + + + + + + + + +
TBL1 - - - - - - + + + + + + + + + +
SIP , Skp1 - - - - - - + + + + + - - - - -
ATP - + + + + + + + + + + + + + + +
Time (min) 60 5 10 15 30 60 5 10 15 30 60 5 10 15 30 60
Lane 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Coomassie stainingSupplementary Figure S4. 
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Figure A2.4. Full scale Coomassie stained SDS-PAGE gel of Figure. 2.3. 
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Figure A2.5. Comparison of Siah-1 expression levels in HEK293T cells. 
 
  
 
a-Tubulin
Siah-1
Supplementary Figure S5. 
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Figure A2.6. Overlay of full 
15
N-
1
H TROSY-HSQC spectra of 
15
N-enriched Siah-SBD 
 in the absence (blue) and presence (red) of β-catenin-FL. 
 
 
 
Supplementary Figure S6. 
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Figure A2.7. 
15
N-
1
H NMR chemical shift perturbation assay using 
15
N- Skp1 and 
TBL1(31-179). A) 
15
N-
1
H HSQC spectra of 
15
N-labeled Skp1 alone at 50 µM (top) 
and after titration of TBL1(31-179) (bottom) at 1:12 molar ratio. B) Zoom in view 
on the spectra in A. The spectra represent the titration of TBL1(31-179) at 1:1 and 
1:12 molar ratio. The experiment was collected in 20 mM Na2HPO4 at pH 7, 20 
mM NaCl and 20 mM βME. 
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Figure A3.1. Purification of FL-TBL1X using Co-affinity, anion exchange and gel 
filtration chromatography. Lane abbreviations are cl- cell lysate, fl - flow through, w -
wash, e - elution, l- load. 
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Figure A3.2. Comparison of TBL1-FBox domain models. Homology model generated 
with Modeller (left), de novo fold of the FBox with Rosetta (right). 
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Figure A3.3. Analysis of TBL1 coiled coil region. A) CD spectra of TBL1(1-124) and (1-
90). B) Secondarys tructure prediction of TBL1(90-120) using the BioInfoBank 
MetaServer. “H” designates helical structure prediction. 
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Figure A3.4. Molar mass distribution of TBL1(1-90), (1-124) and FL proteins from the  
SEC-MALS elution profile 
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Figure A3.5. Limited proteolysis of FL-TBL1X with Chymotrypsin. The digestion 
reaction was carried out at 1:400 ratio of protease:protein at room temperature. 
Aliquots of the reaction were taken at the specified time points. 
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